
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Microb Genom</journal-id><journal-id journal-id-type="iso-abbrev">Microb Genom</journal-id><journal-id journal-id-type="publisher-id">MGen</journal-id><journal-title-group><journal-title>Microbial Genomics</journal-title></journal-title-group><issn pub-type="epub">2057-5858</issn><publisher><publisher-name>Microbiology Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29771235</article-id><article-id pub-id-type="pmc">5994715</article-id><article-id pub-id-type="publisher-id">mgen000180</article-id><article-id pub-id-type="doi">10.1099/mgen.0.000180</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject><subj-group subj-group-type="heading"><subject>Microbial Evolution and Epidemiology: Population Genomics</subject></subj-group></subj-group></article-categories><title-group><article-title><italic>Bordetella pertussis</italic> population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines</article-title><alt-title alt-title-type="recto-page-foot"><ext-link ext-link-type="uri" xlink:href="http://mgen.microbiologyresearch.org">http://mgen.microbiologyresearch.org</ext-link></alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zomer</surname><given-names>Aldert</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Otsuka</surname><given-names>Nao</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hiramatsu</surname><given-names>Yukihiro</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff5"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kamachi</surname><given-names>Kazunari</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nishimura</surname><given-names>Naoko</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ozaki</surname><given-names>Takao</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Poolman</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Geurtsen</surname><given-names>Jeroen</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff id="aff1"><label><sup>1</sup>&#x0200b;</label><institution>Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University</institution>, <addr-line>Utrecht</addr-line>, <country>The Netherlands</country></aff><aff id="aff2"><label><sup>2</sup>&#x0200b;</label><institution>Department of Bacteriology II, National Institute of Infectious Diseases</institution>, <addr-line>Musashimurayama, Tokyo</addr-line>, <country>Japan</country></aff><aff id="aff3"><label><sup>3</sup>&#x0200b;</label><institution>Department of Pediatrics, Konan Kosei Hospital</institution>, <addr-line>Takaya-cho, Konan, Aichi</addr-line>, <country>Japan</country></aff><aff id="aff4"><label><sup>4</sup>&#x0200b;</label><institution>Janssen Vaccines and Prevention B.V.</institution>, <addr-line>Leiden</addr-line>, <country>The Netherlands</country></aff><aff id="aff5"><label><sup>&#x02020;</sup>&#x0200b;</label>Present address: Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.</aff></contrib-group><author-notes><corresp id="cor1"><bold>*Correspondence:</bold> Jeroen Geurtsen, <email xlink:href="jgeurtse@its.jnj.com">jgeurtse@its.jnj.com</email></corresp></author-notes><pub-date pub-type="collection"><month>5</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>17</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>17</day><month>5</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>4</volume><issue>5</issue><elocation-id>e000180</elocation-id><history><date date-type="received"><day>15</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>20</day><month>4</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; Janssen Vaccines &#x00026; Prevention B.V.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</ext-link>, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="mgen-4-180.pdf"/><abstract><p><italic>Bordetella pertussis</italic>, the causative agent of whooping cough, has experienced a resurgence in the past 15 years, despite the existence of both whole-cell and acellular vaccines. Here, we performed whole genome sequencing analysis of 149 clinical strains, provided by the National Institute of Infectious Diseases (NIID), Japan, isolated in 1982&#x02013;2014, after Japan became the first country to adopt acellular vaccines against <italic>B. pertussis</italic>. Additionally, we sequenced 39 strains provided by the Konan Kosei Hospital in Aichi prefecture, Japan, isolated in 2008&#x02013;2013. The genome sequences afforded insight into <italic>B. pertussis</italic> genome variability and population dynamics in Japan, and revealed that the <italic>B. pertussis</italic> population in Japan was characterized by two major clades that divided more than 40&#x02009;years ago. The pertactin gene was disrupted in about 20&#x0200a;% of the 149 NIID isolates, by either a deletion within the signal sequence (&#x00394;SS) or the insertion of IS element IS<italic>481</italic> (<italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic>). Phylogeny suggests that the parent clones for these isolates originated in Japan. Divergence dating traced the first generation of the pertactin-deficient mutants in Japan to around 1990, and indicated that strains containing the alternative pertactin allele <italic>prn2</italic> may have appeared in Japan around 1974. Molecular clock data suggested that observed fluctuations in <italic>B. pertussis</italic> population size may have coincided with changes in vaccine usage in the country. The continuing failure to eradicate the disease warrants an exploration of novel vaccine compositions.</p></abstract><kwd-group><kwd><italic>Bordetella pertussis</italic></kwd><kwd>pertactin</kwd><kwd>phylogenomics</kwd><kwd>acellular vaccine</kwd><kwd>epidemiology</kwd><kwd>Japan</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>OpenAccessEmbargo</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1-2"><title>Data Summary</title><p>1. The genome sequence reads of all 188 <italic>B. pertussis</italic> strains were deposited in the European Nucleotide Archive at <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/">www.ebi.ac.uk/</ext-link> under&#x02009;project number PRJEB18624.</p><p>2. All supporting data are accessible as supplementary tables. Data include: (1) metadata, sequencing statistics and typing results on 188 Japanese <italic>B. pertussis</italic> strains (Table S1, available in the online version of this article); (2) metadata and typing results on 943 <italic>B. pertussis</italic> strains from this study and the literature (Table S2); (3) sequences and accession numbers of major <italic>B. pertussis</italic> antigen alleles utilized during <italic>in silico</italic> phenotyping of sequenced strains (Table S3); (4) all SNPs detected among the 188 contemporary Japanese <italic>B. pertussis</italic> isolates and strain Tohama I (Table S4); (5) SNPs overrepresented in isolates with <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic> and/or <italic>prn</italic>&#x00394;SS mutations (Table S5); and (6) rates of genetic variants observed for the orthologous groups of core genes from 188 <italic>B. pertussis</italic> isolates from Japan, 1982&#x02013;2014, and Tohama I (Table S6).</p><boxed-text position="float"><caption><title>Impact Statement</title></caption><p>Japan was the first country to adopt acellular vaccines against <italic>Bordetella pertussis</italic>, the causative agent of whooping cough. After switching from whole-cell to acellular vaccines, a resurgence in the incidence of pertussis in many Western countries, including Japan, was observed. Whole genome sequencing of <italic>B. pertussis</italic> strains harvested across this country identified the <italic>B. pertussis</italic> population dynamics in this environment. In addition to the existence of strains belonging to two different clades that diverged over 40&#x02009;years ago, clonal spread of pertactin-negative strains was observed in Japan. Our data revealed that these isolates may have arisen in Japan around 1990. We also show a potential direct impact of changes in vaccine usage on the <italic>B. pertussis</italic> population size in the country, and present data on highly variant and very stable bacterial proteins that may aid the development of novel vaccine formulations to better fight the disease.</p></boxed-text></sec><sec sec-type="intro" id="s1-4"><title>Introduction</title><p><italic>Bordetella pertussis</italic> is a non-motile, aerobic, Gram-negative coccobacillus that causes whooping cough (pertussis) in humans. Pertussis is a highly contagious disease of the respiratory tract that, in rare cases, can be fatal, particularly in neonates. Fortunately, vaccines have been developed that reduce disease impact and limit spread of the bacterium in the human population.</p><p>More than 100&#x02009;years ago, whole-cell vaccines (WCVs) against <italic>B. pertussis</italic> were licensed in the USA [<xref rid="R1" ref-type="bibr">1</xref>], and were subsequently adopted in many industrialized countries as a combinatorial mixture with diphtheria and tetanus toxoids. In the mid-1970s, increasing reports of adverse reactions to WCV preparations in Japan resulted in a government decision to temporarily halt mass <italic>B. pertussis</italic> vaccination in 1975 and to increase vaccination age after reintroduction of the programme [<xref rid="R2" ref-type="bibr">2</xref>]. As a consequence, the development of safer vaccination alternatives was prioritized, and in 1981 Japan was the first country to develop acellular pertussis vaccines (ACVs) and to adopt these for use in the general population [<xref rid="R2" ref-type="bibr">2, 3</xref>]. The ACVs invariably contained inactivated pertussis toxin and filamentous haemagglutinin, and were often supplemented with <italic>fim2</italic>-encoded fimbriae and pertactin, the latter an outer membrane protein that promotes adhesion to human tracheal epithelial cells of the host [<xref rid="R4" ref-type="bibr">4</xref>]. ACVs helped regain control over pertussis disease in Japan [<xref rid="R5" ref-type="bibr">5</xref>], and were shown to be as protective as whole cell-based vaccine preparations [<xref rid="R6" ref-type="bibr">6</xref>].</p><p>Despite growing vaccine coverage, worldwide incidence of pertussis has increased in recent years. Possible explanations for this resurgence include (i) genetic changes in circulating <italic>B. pertussis</italic> strains (see below), (ii) waning of vaccine-induced immunity, which may be rectifiable by repeated vaccination [<xref rid="R7" ref-type="bibr">7&#x02013;11</xref>], (iii) increased awareness and reporting of pertussis cases, and (iv) an improved diagnosis of pertussis disease (summarized in [<xref rid="R12" ref-type="bibr">12</xref>]). In addition, studies in baboons suggest that ACVs, while protecting against disease, have limited impact, if any, on infection with and transmission of <italic>B. pertussis</italic> [<xref rid="R13" ref-type="bibr">13, 14</xref>].</p><p>Both pre-dating and after ACV development, genomic variations have been observed for ACV-targeted antigens [<xref rid="R9" ref-type="bibr">9, 15&#x02013;17</xref>], some of which may be the result of vaccine-induced selective pressure. A mutation in the promoter region of the operon encoding the pertussis toxin, <italic>ptxP3</italic>, resulted in production of elevated levels of the toxin [<xref rid="R18" ref-type="bibr">18</xref>], and now predominates in many countries where ACVs have been deployed [<xref rid="R19" ref-type="bibr">19&#x02013;22</xref>]. Similarly, the non-vaccine pertactin allele <italic>prn2</italic> has become prevalent in many industrialized countries, including Australia, Japan, the UK, the Netherlands, Canada, Austria and the USA [<xref rid="R20" ref-type="bibr">20, 22&#x02013;27</xref>].</p><p>Of particular interest is the reported increase in <italic>B. pertussis</italic> isolates not expressing pertactin at all (Prn<sup>&#x02212;</sup>), observed in many countries that have adopted ACVs [<xref rid="R21" ref-type="bibr">21, 28&#x02013;35</xref>]. The rate of Prn<sup>&#x02212;</sup> isolates significantly correlates with vaccine use in the USA [<xref rid="R33" ref-type="bibr">33</xref>]. In Japan, the first known pertactin-deficient (Prn<sup>&#x02212;</sup>) <italic>B. pertussis</italic> strain was harvested in 1997, marking the beginning of an increase of the fraction of pertactin-negative strains in the Japanese <italic>B. pertussis</italic> population to over 30&#x0200a;% during the first decade of the 21st century [<xref rid="R36" ref-type="bibr">36, 37</xref>]. The loss of pertactin by some <italic>B. pertussis</italic> strains does not influence disease severity [<xref rid="R38" ref-type="bibr">38, 39</xref>]. However, these isolates show increased fitness and/or prolonged infection times in animal host populations immunized with ACVs [<xref rid="R40" ref-type="bibr">40, 41</xref>]. Notably, an increased prevalence of Prn<sup>&#x02013;</sup> strains is often reported in countries that use pertactin-comprising ACVs for general vaccination [<xref rid="R21" ref-type="bibr">21, 28&#x02013;30, 32, 35</xref>]. However, a recent study revealed a surprising decrease in <italic>B. pertussis</italic> Prn<sup>&#x02013;</sup> frequency in Japan in the past 3 years [<xref rid="R42" ref-type="bibr">42</xref>].</p><p>Many <italic>B. pertussis</italic> genomes have been sequenced and deposited in public repositories. Genomes of the strains harvested during the pertussis epidemic in Australia of 2008&#x02013;2012 revealed microevolution events, predominant <italic>prn2</italic> alleles and mixing of strains from a concurrent epidemic in the UK [<xref rid="R43" ref-type="bibr">43</xref>]. Genome sequencing performed on strains of that UK outbreak revealed that the genes encoding antigens present in ACVs may evolve at a faster rate than other surface proteins of the bacterium, potentially suggesting vaccine-induced selective pressure [<xref rid="R25" ref-type="bibr">25</xref>]. Genome sequencing confirmed clonal expansion of <italic>B. pertussis</italic> on four occasions in the Netherlands [<xref rid="R26" ref-type="bibr">26</xref>] and suggested differences in the mutation rates of the bacterium depending on vaccination coverage and method in China, the Netherlands and Finland [<xref rid="R44" ref-type="bibr">44</xref>]. An extensive study examined and characterized the global population structure of <italic>B. pertussis</italic>, sequencing over 300 isolates, harvested worldwide between 1920 and 2010 [<xref rid="R16" ref-type="bibr">16</xref>]. This study included 17 strains collected in Japan between 1988 and 2007, but seemed not to sample any Prn<sup>&#x02212;</sup> isolates.</p><p>The aim of this study was to further monitor and analyse the <italic>B. pertussis</italic> population dynamics in Japan as the first country to adopt ACV vaccination. To do this, a set of representative <italic>B. pertussis</italic> clinical isolates collected between 1982 and 2014 was analysed by whole-genome sequencing. Our hope was to pinpoint the selection of the first generation of Prn<sup>&#x02212;</sup> strains, and to put these into an evolutionary context of currently circulating Prn<sup>&#x02013;</sup> and Prn<sup>+</sup> strains, in Japan.</p></sec><sec sec-type="methods" id="s1-5"><title>Methods</title><sec id="s2-5-1"><title>Selection of <italic>B. pertussis</italic> clinical isolates</title><p>A set of Japanese <italic>B. pertussis</italic> isolates was obtained from the Konan Kosei Hospital (<italic>n</italic>=39), representing all <italic>B. pertussis</italic> cases in that hospital between 2008 and 2013. In addition, isolates were procured from the National Institute of Infectious Diseases of Japan (NIID; <italic>n</italic>=151, genome sequences were obtained from 149 of these), representing a random pool of clinical isolates collected from various locations in Japan between 1982 and 2014. A summary of strain characteristics is given in <xref ref-type="table" rid="T1">Table 1</xref>, while a more detailed description of every strain and associated metadata is given in Table S1. The isolates originated from 29 different locations across all five major islands of the country (Hokkaido, Honshu, Shikoku, Kyushu and Okinawa).</p><table-wrap id="T1" position="float"><label>Table 1.</label><caption><title>Summary of Japanese <italic>B. pertussis</italic> strains investigated by whole genome sequencing</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="left" colspan="1">Period</th><th rowspan="2" align="center" colspan="1">Total no. of isolates*</th><th rowspan="2" align="center" colspan="1">No. of locations</th><th rowspan="2" align="center" colspan="1">No. of &#x02206;<italic>prn</italic> isolates</th><th rowspan="2" align="center" colspan="1">&#x02206;<italic>prn</italic> mechanisms</th><th colspan="6" align="center" rowspan="1">Identified gene alleles</th></tr><tr><th align="center" rowspan="1" colspan="1"><italic>prn</italic></th><th align="center" rowspan="1" colspan="1"><italic>ptxP</italic></th><th align="center" rowspan="1" colspan="1"><italic>ptxA</italic></th><th align="center" rowspan="1" colspan="1"><italic>fim2</italic></th><th align="center" rowspan="1" colspan="1"><italic>fim3</italic></th><th align="center" rowspan="1" colspan="1"><italic>fhaB</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1981&#x02013;1985</td><td align="center" rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">mRNA&#x02193;&#x02020;</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">1986&#x02013;1990</td><td align="center" rowspan="1" colspan="1">13</td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1, 8</td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">1991&#x02013;1995</td><td align="center" rowspan="1" colspan="1">18</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1, 3</td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">1996&#x02013;2000</td><td align="center" rowspan="1" colspan="1">42</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1"><italic>prn</italic>&#x02206;SS, <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic></td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1, 3</td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">2001&#x02013;2005</td><td align="center" rowspan="1" colspan="1">23</td><td align="char" char="." rowspan="1" colspan="1">16</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1"><italic>prn</italic>&#x02206;SS, <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic></td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1, 3, 8</td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">2006&#x02013;2010</td><td align="center" rowspan="1" colspan="1">43 (19)</td><td align="char" char="." rowspan="1" colspan="1">15</td><td align="char" char="." rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1"><italic>prn</italic>&#x02206;SS, <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic></td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1, 3</td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1, 2, 4</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">2011&#x02013;2014</td><td align="center" rowspan="1" colspan="1">40 (20)</td><td align="char" char="." rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1"><italic>prn</italic>&#x02206;SS</td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1, 3</td><td align="center" rowspan="1" colspan="1">1, 2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1, 2, 4</td><td align="center" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p id="t1_1">*The number of isolates from Konan Kosei is shown in parentheses.</p></fn><fn id="tblfn2"><p id="t1_2">&#x02020;One isolate exhibited reduced <italic>prn</italic> mRNA production.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-5-2"><title>Genome sequencing and assembly</title><p>Whole genome sequencing and assembly were performed by BaseClear B.V. Paired-end sequence reads (2&#x000d7;125&#x02009;bp) were generated using the Illumina HiSeq2500 system. FASTQ sequence files were generated using the Illumina Casava pipeline version 1.8.3. Initial quality assessment was based on data passing the Illumina Chastity filtering. Subsequently, reads containing adapters and/or PhiX control signal were removed using an in-house filtering protocol. The second quality assessment was based on the remaining reads using the FASTQC quality control tool version 0.10.0. The quality of the FASTQ sequences was enhanced by trimming off low-quality bases using the &#x02018;Trim sequences&#x02019; option of Qiagen&#x02019;s CLC Genomics Workbench version 7.5 or 8.0. The quality-filtered sequence reads were assembled into contigs, using SPAdes v3.10.1 with default settings, including the <italic>careful</italic> mode. Final genome coverage and contig numbers are shown in Table S1.</p><p>The genome sequence reads of all 188 <italic>B. pertussis</italic> strains were deposited in the European Nucleotide Archive at <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/">www.ebi.ac.uk/</ext-link> under&#x02009;project number PRJEB18624.</p></sec><sec id="s2-5-3"><title>Phylogenetic reconstruction</title><p>Illumina sequence reads or complete genomes of all sequenced <italic>B. pertussis</italic> isolates from this study, as well as qualifying <italic>B. pertussis</italic> genome sequences available from GenBank and those deposited from Sealey and others [<xref rid="R25" ref-type="bibr">25</xref>] in the European Nucleotide Archive ENA (755 GenBank and ENA genomes, access date 9 Febuary 2018) were mapped against the closed genome of <italic>B. pertussis</italic> Tohama I [<xref rid="R45" ref-type="bibr">45</xref>], using Snippy with default settings [<xref rid="R46" ref-type="bibr">46</xref>]. Genomes were only included when coverage was sufficient (defined as fewer than 300&#x02009;kb with a coverage of &#x0003c;10) and when isolation location and date were provided. Typing data were extracted from various reference sources [<xref rid="R16" ref-type="bibr">16, 25, 45, 47&#x02013;52</xref>] or inferred from sequenced genomes (Table S2). Phylogenetic trees with and without inclusion of the 755 worldwide isolates were reconstructed using FastTree2 [<xref rid="R53" ref-type="bibr">53</xref>] with a generalized time-reversible (GTR) model with gamma correction on the resulting core genome alignment. The resulting trees were rooted using the genome of <italic>Bordetella bronchiseptica</italic> MO149 [<xref rid="R54" ref-type="bibr">54</xref>] prior to visualization using iTOL [<xref rid="R55" ref-type="bibr">55</xref>].</p></sec><sec id="s2-5-4"><title><italic>In silico</italic> typing and phenotypic analysis of isolates</title><p>For <italic>in silico</italic> typing, alleles of the genes <italic>ptxA</italic>, <italic>ptxP</italic>, <italic>fim2</italic>, <italic>fim3</italic>, <italic>prn</italic> and <italic>fhaB</italic> were aligned against assembled whole genome sequences of the isolates using <sc>blast</sc> +2.4.0 (<ext-link ext-link-type="ftp" xlink:href="ftp://ftp.ncbi.nlm.nih.gov/blast/executables/LATEST">ftp://ftp.ncbi.nlm.nih.gov/blast/executables/LATEST</ext-link>). A gene was assigned an allele if a 100&#x0200a;% match was found against the polymorphic typing region, as previously defined [<xref rid="R56" ref-type="bibr">56, 57</xref>]. Apparent mutations were manually verified from the sequence alignments. The numbers of alleles considered were as follows: <italic>prn</italic>, 17 alleles, <italic>ptxP</italic>, 11 alleles, <italic>ptxA</italic>, 3 alleles; <italic>fim2</italic>, 2 alleles; <italic>fim3</italic>, 6 alleles; <italic>fhaB</italic>, 2 alleles. Alelle sequences and accession numbers are shown in Table S3. We used assembly data for this analysis, as well as for SNP and gene variant detection (below), because the use of mapped reads may disable detection of insertions and deletions.</p><p>Phenotypic analyses for expression of Prn, Fim2 and Fim3 were performed as previously described [<xref rid="R36" ref-type="bibr">36</xref>], using immunoblotting of 1&#x02009;&#x000b5;g protein samples per lane (Prn) and whole-cell ELISA techniques (Fim2, Fim3).</p></sec><sec id="s2-5-5"><title>Divergence dating and recombination analysis</title><p>A core genome alignment was created on the isolates from this study using Parsnp v1.2 [<xref rid="R58" ref-type="bibr">58</xref>], and SNPs were detected from the alignment. SNPs closer than 1&#x02009;kb to each other were excluded to remove rapidly evolving regions or regions that are under selective pressure which could affect the temporal signal. This approach resulted in removal of 400 SNPs from consideration. Pearson correlation between root to tip distance of the phylogenetic tree and isolate date was significant (<italic>P</italic>&#x0003c;0.0001, <italic>R</italic><sup>2</sup>=0.38), suggesting a strong temporal signal in the SNP data. Divergence dating was performed in <sc>beast</sc> [<xref rid="R59" ref-type="bibr">59</xref>], using the isolation dates as tip dates in the phylogenetic tree with a GTR model of evolution. An exponential clock model was used in combination with a Bayesian skyline demographic model with four groups, essentially as previously described [<xref rid="R16" ref-type="bibr">16</xref>]. A Markov chain was run for 100&#x0200a;000&#x0200a;000 generations, with parameter values sampled every 10&#x0200a;000 generations. The chain was checked for expected sample sizes (ESSs)&#x0003e;200 using Tracer (<ext-link ext-link-type="uri" xlink:href="http://tree.bio.ed.ac.uk/software/tracer/">http://tree.bio.ed.ac.uk/software/tracer/</ext-link>), with the first 10&#x0200a;000&#x0200a;000 chains removed [<xref rid="R59" ref-type="bibr">59</xref>]. A Bayesian skyline plot was drawn in Tracer with dates between 1950 and 2014. A maximum clade credibility tree was computed with TreeAnnotator, keeping tree heights intact and with a burn-in of 10&#x0200a;000&#x0200a;000 chains. <sc>beast</sc> results were visualized using Tracer and Figtree (<ext-link ext-link-type="uri" xlink:href="http://tree.bio.ed.ac.uk/software/figtree/">http://tree.bio.ed.ac.uk/software/figtree/</ext-link>).</p></sec><sec id="s2-5-6"><title>Detection of SNPs, and association of SNPs with Prn<sup>+</sup> and&#x02009;Prn<sup>&#x02013;</sup>
<italic>B. pertussis</italic> isolates</title><p>Complete genome sequences of <italic>B. pertussis</italic> isolates were compared using Parsnp v1.2 [<xref rid="R58" ref-type="bibr">58</xref>]. Presence and absence of core genome SNPs, as identified by Parsnp, were tested for their prevalence in Prn<sup>&#x02212;</sup> and Prn<sup>+</sup> strains using Fisher's exact 2&#x000d7;2&#x02009;contingency tests.</p></sec><sec id="s2-5-7"><title>Rates of genetic variants</title><p>Proteins were clustered into orthologous groups (OGs) using Roary [<xref rid="R60" ref-type="bibr">60</xref>] with default settings. Prior to clustering, genes containing transposase sequences were removed using <sc>blast</sc> against genes coding for transposases [<xref rid="R61" ref-type="bibr">61</xref>], to prevent spurious clustering of proteins on these sequences. Amino acid and nucleotide sequences of these OGs were compared and every unique gene or protein sequence was assigned an allele number. Unique numbers of variants per OG were counted and summarized. Truncated genes shorter than 90&#x0200a;% of their supposed length were removed from the analysis. The computed variant numbers per OG (minus 1) were finally divided by the length of the represented gene to generate a density value that allows cross-comparisons between genes.</p><p>Note that a genetic variant is based on the entire ORF sequence, while <italic>prn</italic>, <italic>ptxP</italic>, <italic>ptxA</italic>, <italic>fim2</italic>, <italic>fim3</italic> and <italic>fhaB</italic> alleles only pertain to the typing regions defined for each gene. Consequently, there can be more genetic variants than alleles for these genes.</p></sec></sec><sec id="s1-6"><title>Results and discussion</title><sec id="s2-6-1"><title>Phylogenetic analysis of pertussis disease in Japan reveals two major clades</title><p>To gain insight into the <italic>B. pertussis</italic> phylogeny and population dynamics in the country that first adopted ACVs, we sequenced the genomes of 149 clinical <italic>B. pertussis</italic> isolates observed across Japan between 1982 and 2014. These strains were provided by the NIID. In addition, we sequenced the genomes of 39 isolates from the Konan Kosei Hospital, a local healthcare facility in Aichi prefecture in Japan, with isolation dates from 2008 to 2013. Overall, about 1.44&#x02009;million reads (<sc>sd</sc>&#x000b1;0.3) were obtained per isolate, resulting in an average genome coverage of 88.2&#x000d7; (<sc>sd</sc>&#x000b1;18.3). Core genome alignment, which included 3&#x0200a;552&#x0200a;899&#x02009;bp DNA, revealed a total of 1272 SNPs between the 188 isolates and <italic>B. pertussis</italic> strain Tohama I, the strain used for preparation of the ACVs that are utilized in Japan.</p><p>Phylogenetic reconstruction based on 872 SNPs identified in the core genome present in all sequenced strains revealed that two clades of <italic>B. pertussis</italic> represent the primary causes of pertussis disease in Japan from 1982 to 2014 (<xref ref-type="fig" rid="F1">Fig. 1</xref>). This analysis excluded SNPs that were within 1&#x02009;kb of each other. The clades are characterized by defined differences in the alleles of major antigens of the bacterium. The first clade consists of 112 isolates predominated by exhibition of pertussis toxin allele <italic>ptxA2</italic>, pertussis toxin promoter allele <italic>ptxP1</italic> and pertactin allele <italic>prn1</italic>. The vast majority of the 73 strains forming the second clade contain the <italic>ptxA1&#x0200a;:&#x0200a;ptxP3&#x0200a;:&#x0200a;prn2</italic> combination. Median isolation dates reveal the first clade (median isolation year 2000) to contain overall older strains than the second clade (median isolation year 2009), indicating an overall increase in prevalence of strains containing the <italic>prn2</italic> and <italic>ptxP3</italic> alleles. A closer look at the temporal prevalence of different alleles of the <italic>prn</italic> and <italic>ptxA</italic> genes and <italic>ptxP</italic> confirms this observation (<xref ref-type="fig" rid="F2">Fig. 2</xref>a&#x02013;c).</p><fig id="F1" fig-type="figure" position="float"><label>Fig. 1.</label><caption><p>Phylogeny of <italic>B. pertussis</italic> isolates in Japan. Shaded regions indicate time periods of WCV and ACV use, with the notable gap in vaccine use in 1975. Isolation year, alleles of <italic>ptxP</italic>, <italic>ptxA</italic> and <italic>prn</italic>, as well as pertactin deficiency is indicated for each isolate on the right. The clustered isolates of two variants of pertactin-deficient strains are highlighted in red (<italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic>) and green (&#x00394;SS). Notable nodes are illustrated and <sc>beast</sc>-based divergence dating results are shown for the pertactin-deficient variants.</p></caption><graphic xlink:href="mgen-4-180-g001"/></fig><fig id="F2" fig-type="figure" position="float"><label>Fig. 2.</label><caption><p>Changes in <italic>B. pertussis</italic> allele frequencies of <italic>ptxP</italic>, <italic>ptxA</italic> and <italic>prn</italic> as well as pertactin deficiency rates over time in Japan, 1982&#x02013;2014. Konan Kosei isolates were excluded from the calculation.</p></caption><graphic xlink:href="mgen-4-180-g002"/></fig><p>A minor third clade was also identified, which consisted of reference isolate <italic>B. pertussis</italic> Tohama I (<italic>ptxA1&#x0200a;:&#x0200a;ptxP1&#x0200a;:&#x0200a;prn1</italic>) and three additional isolates (BP56, BP121 and BP194), all harvested before 2000. The population structure in Japan broadly mirrors observations made in other countries. However, we noted one minor distinction. A separate clonally expanding clade that included <italic>ptxA1&#x0200a;:&#x0200a;ptxP3&#x0200a;:&#x0200a;prn2</italic> strains with the <italic>fim3-2</italic> allele was detected in the UK and the Netherlands in the early 2000s [<xref rid="R25" ref-type="bibr">25, 26</xref>]. A small <italic>fim3-2</italic> clade of eight isolates with the same antigenic combination was also present in Japan, but has not expanded to the same predominance and clusters deep within clade II (<xref ref-type="fig" rid="F1">Figs 1</xref> and <xref ref-type="fig" rid="F3">3</xref>).</p><fig id="F3" fig-type="figure" position="float"><label>Fig. 3.</label><caption><p>Phylogenetic tree of <italic>B. pertussis</italic> isolates in Japan, contextualized with worldwide isolates. Japanese isolates are on an orange background. Worldwide isolates are those investigated in previous studies [<xref rid="R16" ref-type="bibr">16, 25</xref>] and all other qualifying genome sequences deposited in GenBank by 9 February 2018 (see Methods). Alleles of <italic>fim3</italic>, <italic>fim2</italic>, <italic>prn</italic>, <italic>ptxP</italic> and <italic>ptxA</italic> and isolation year are colour-coded, as indicated on the left. The variants of pertactin deficiency are highlighted in blue and green (<italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic>), red (&#x00394;SS) and grey (other). Notable nodes are annotated. Circles represent, from outermost inwards, <italic>fim3</italic>, <italic>fim2</italic>, <italic>prn</italic>, <italic>ptxP</italic> and <italic>ptxA</italic> allele status, followed by isolation year of each strain and <italic>prn</italic> mutation status. Distances in the tree were adjusted to sites per core genome and square root transformed to enhance resolution at short phylogenetic distances.</p></caption><graphic xlink:href="mgen-4-180-g003"/></fig></sec><sec id="s2-6-2"><title>Comparison with previously sequenced isolates and worldwide context</title><p>Extensive earlier work sequenced <italic>B. pertussis</italic> genomes obtained worldwide, to gain insight into evolutionary patterns on a global scale [<xref rid="R16" ref-type="bibr">16</xref>]. This study included 17 strains harvested from Japan between 1988 and 2007 and pertactin deficiency had not been recognized in the genome assemblies for any of these strains. However, an earlier report had suggested lack of pertactin in one of these isolates, strain BP310 [<xref rid="R36" ref-type="bibr">36</xref>]. We therefore re-sequenced nine of these 17 strains (BP22, BP120, BP128, BP121, BP31, BP56, BP119, BP227, BP310), and confirmed a &#x00394;SS pertactin phenotype in strain BP310. After assembly of the reads from all 346 isolates included in the earlier study [<xref rid="R16" ref-type="bibr">16</xref>], previously unnoticed &#x00394;SS pertactin genotypes were also noted in two further strains, B050, harvested in 2007 in Australia, and B107, a 2002 isolate from Hong Kong. A phylogenetic placement of our panel of Japanese isolates with the strains sequenced as part of the worldwide investigation in 2014 provided a worldwide context for the Japanese isolates. This context was expanded to include all other qualifying <italic>B. pertussis</italic> genome sequences in GenBank and ENA (see Methods, <xref ref-type="fig" rid="F3">Fig. 3</xref>), for a total of 943 genomes. Among other observations, the tree indicated that three additional isolates, harvested in 2010&#x02013;2012 in the USA, clustered with the Japanese <italic>prn</italic>&#x00394;SS isolates and were possibly introduced into North America from Japan.</p><p>The Japanese isolates populated all major branches of the global tree, indicating that the parameters used for tree reconstruction minimized any systematic difference introduced by the distinct sequencing approaches for the different strains. However, no Japanese isolate was identified that populated the intermediate evolutionary clade after the appearance of the <italic>prn2</italic> allele but pre-dating the introduction of the <italic>ptxP3</italic> mutation, i.e. <italic>ptxP1&#x0200a;:&#x0200a;prn2</italic>.</p><p>We observed strong geographical clustering of the Japanese <italic>ptxA2</italic> isolates, suggesting that they had evolved there for a prolonged amount of time and remained clonal. This was unexpected, given the lack of geographical clustering of worldwide <italic>B. pertussis</italic> isolates observed elsewhere [<xref rid="R16" ref-type="bibr">16</xref>]. However, the tree intimated a few Japanese isolates to have been introduced into the country from elsewhere, by placing these in close proximity to older strains from the worldwide panel. These &#x02018;island&#x02019; clones are exemplified by BP28, a strain that closely resembles B250, a Swedish isolate harvested in 1970, and isolates BP227 and BP316, which are similar to B014, a strain harvested in 1971 in Australia, and two European strains isolated in 1968 (B071 from Denmark and B221 from Poland). Conversely, a few strains found in the global strain panel had very close relatives in the Japanese strain panel, such as the previously mentioned three USA strains clustering with the <italic>prn</italic>&#x00394;SS isolates.</p><p>Three isolates from our study, BP56, BP194 and BP121, two Japanese isolates from the worldwide panel (B133 and B135, harvested in the late 1990s), and one additional Japanese isolate from 1950 (GCA_002083095) clustered in an outgroup with the model isolate Tohama I, and represent a remote branch that has become extremely rare and possibly extinct in modern Japan. On a worldwide scale, this small cluster included a few other older strains, such as J042, an isolate from 1947 isolated in the USA, as well as B068 and GCA_001605275, slightly more distant Chinese isolates from the 1950s.</p></sec><sec id="s2-6-3"><title>Allele typing</title><p><italic>In silico</italic> typing was performed on all sequenced isolates for major antigens of <italic>B. pertussis</italic>, i.e. <italic>ptxA</italic>, <italic>fim2</italic>, <italic>fim3</italic>, <italic>prn</italic> and <italic>fhaB</italic>, as well as the pertussis toxin promoter region <italic>ptxP</italic>. Results are shown in <xref ref-type="table" rid="T1">Table 1</xref> and, in single-strain resolution, in Table S1. For <italic>ptxA</italic>, two types were found, <italic>ptxA1</italic> (<italic>n</italic>=73) and <italic>ptxA2</italic> (<italic>n</italic>=115), separated along clade lines. For <italic>ptxP</italic>, three types were found, <italic>ptxP1</italic> (<italic>n</italic>=119), <italic>ptxP3</italic> (<italic>n</italic>=67) and <italic>ptxP8</italic> (<italic>n</italic>=2). All <italic>ptxP3</italic> isolates and 6/119 <italic>ptxP1</italic> isolates constituted clade II of the phylogenetic tree shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>, while two <italic>ptxP1</italic> strains clustered with the type strain Tohama I in the small and possibly extinct clade III. The remaining 111 <italic>ptxP1</italic> strains and the two <italic>ptxP8</italic> isolates formed clade I. All strains contained <italic>fim2-1</italic> (<italic>n</italic>=188). For <italic>fim3</italic>, three types were found, <italic>fim3-1</italic> (<italic>n</italic>=177), <italic>fim3-2</italic> (<italic>n</italic>=8) and <italic>fim3-4</italic> (<italic>n</italic>=3). For <italic>fhaB</italic>, only <italic>fhaB-1</italic> was detected (<italic>n</italic>=188).</p><p>Based on previously defined amino acid repeat variations in pertactin sequences [<xref rid="R57" ref-type="bibr">57</xref>], two <italic>prn</italic> types were genotypically identified in the strain panel, <italic>prn1</italic> (<italic>n</italic>=121) and <italic>prn2</italic> (<italic>n</italic>=67). Among the <italic>prn1</italic> strains, 38 had a deletion in their 5&#x02032; signal sequence-encoding region (&#x00394;SS) and nine were interrupted by an IS<italic>481</italic> element (<italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic>) in their <italic>prn</italic> gene.</p></sec><sec id="s2-6-4"><title>Allelic shifts and deficiency of pertactin</title><p>A decline in <italic>prn1</italic> frequency, paralleling ascending <italic>ptxA1</italic> and <italic>ptxP3</italic> prevalence, was observed in existing isolates in Japan, a shift that experienced its biggest momentum at around 2010 (<xref ref-type="fig" rid="F2">Fig. 2a, b</xref>). These events mirror similar shifts toward alternative antigen alleles observed earlier on a worldwide scale, primarily in the industrialized world with high vaccine coverage. The start of this worldwide shift pre-dated use of ACV preparations and suggested exertion of selective immune pressure on pertactin by WCVs. Consequently, allelic variation of <italic>B. pertussis</italic> antigens probably contributed to survival of <italic>B. pertussis</italic> after WCV adoption, as previously championed [<xref rid="R16" ref-type="bibr">16</xref>].</p><p>The vaccine strain Tohama I expresses <italic>prn1</italic> and <italic>ptxA2</italic>, and the recent shift favours strains expressing antigen variants not included in the ACV preparations customary in Japan. Evidence of increasing incidence of pertactin variants not represented in vaccine preparations had been presented before (exemplified by [<xref rid="R17" ref-type="bibr">17, 62</xref>]), and similar changes had been described, beginning in the WCV era, on a worldwide scale [<xref rid="R16" ref-type="bibr">16</xref>]. However, this observation may be restricted to countries with high vaccine coverage, as countries with lower, or delayed, vaccine coverage have not (yet) experienced similar predominance of <italic>prn2</italic> isolates [<xref rid="R44" ref-type="bibr">44, 63</xref>], or are apparently devoid of <italic>prn2</italic> strains [<xref rid="R64" ref-type="bibr">64</xref>]. Notably, an allele shift to <italic>prn2:ptxA1</italic> resulted in prolonged survival in murine test animals treated with an ACV derived from the <italic>prn1</italic> isolate Tohama I [<xref rid="R65" ref-type="bibr">65</xref>].</p><p>Divergence dating using <sc>beast</sc> on a core genome alignment (see Methods) places the divergence node between <italic>prn2</italic> and <italic>prn1</italic> strains in Japan at around 1974, well within the period of WCV usage, but pre-dating the development of ACVs against <italic>B. pertussis</italic>. This suggests that WCVs induce pertactin-selective immune pressure. Allelic variation of pertactin has been observed in many countries prior to introduction of ACVs, during periods of high WCV coverage [<xref rid="R66" ref-type="bibr">66&#x02013;68</xref>].</p><p>Pre-dating the decline in <italic>prn1</italic> predominance, pertactin-deficient isolates appeared in the mid-1990s in Japan. In our strain panel, this deficiency occurred exclusively in <italic>prn1</italic> alleles, in two ways. The first consists of an integration of the insertion sequence IS<italic>481</italic> (in the forward orientation) at nucleotide position 1598 of the <italic>prn</italic> gene (equivalent to nucleotide position 1613 in <italic>prn2</italic>). The second consists of a deletion of nucleotides 26&#x02013;109 in the signal sequence of the <italic>prn</italic> gene. Both disruption of the gene by IS<italic>481</italic> and signal sequence deletion have been previously observed and described in Japanese <italic>B. pertussis</italic> Prn<sup>&#x02013;</sup> isolates [<xref rid="R37" ref-type="bibr">37</xref>], and IS<italic>481</italic> insertions, although in different locations within the gene, were also observed elsewhere [<xref rid="R30" ref-type="bibr">30, 32, 34</xref>]. In our strain selection, divergence dating estimates the divergence of the <italic>prn</italic>&#x00394;SS cluster in the phylogenetic tree depicted in <xref ref-type="fig" rid="F1">Fig. 1</xref> to have occurred in 1990 [95&#x0200a;% confidence interval (CI): 1989&#x02013;1993]. In the same year, a <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic>-containing mutant cluster may have first appeared (95&#x0200a;%&#x02009;CI: 1989&#x02013;1995). A lineage that included a third single <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic> isolate, BP118, was predicted to have diverged from an intact ancestor around 1994 (95&#x0200a;% CI: 1991&#x02013;1997). Such pertactin-deficient isolates reached a maximal frequency in Japan of over 40&#x0200a;% in the early 2000s (<xref ref-type="fig" rid="F2">Fig. 2d</xref>). The phylogenetic tree including the worldwide strain collection (<xref ref-type="fig" rid="F3">Fig. 3</xref>) does not detect a close ancestor to the Japanese <italic>prn</italic>&#x00394;SS isolates in the worldwide collection, and therefore suggests this cluster to have arisen in Japan. Similarly, no close relative of the <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic> strains isolated in Japan was detected in the panel of worldwide isolates.</p><p>However, Prn<sup>&#x02013;</sup> isolates failed to take over the <italic>B. pertussis</italic> population in Japan, and a recent study reveals a decrease in <italic>B. pertussis</italic> Prn<sup>&#x02013;</sup> frequency in Japan to below 10&#x0200a;% in the past 3 years [<xref rid="R42" ref-type="bibr">42</xref>]. One reason for this drop may be the rising predominance of <italic>prn2</italic>-containing isolates, many of which have close relatives elsewhere in the world (illustrated in <xref ref-type="fig" rid="F3">Fig. 3</xref>). However, this drop in pertactin-negative <italic>B. pertussis</italic> strains may also be caused, in part, by the wide introduction of new ACV preparations in Japan in 2012 that do not contain pertactin [<xref rid="R42" ref-type="bibr">42</xref>]. It remains unclear why Prn<sup>&#x02212;</sup> isolates thrive to various degrees in different territories, exemplified by their rapidly increasing prevalence in Australia [<xref rid="R32" ref-type="bibr">32, 43</xref>] and the USA [<xref rid="R69" ref-type="bibr">69, 70</xref>], but continued low frequency in neighbouring Canada and the UK [<xref rid="R71" ref-type="bibr">71</xref>]. One explanation assumes that differential vaccine preparations and immunization regimens impose different levels of immune pressure on pertactin, dictating a varying need for and availability of possible escape routes.</p><p>While more than a dozen genetic disruption mechanisms of pertactin have been identified, including alternative IS elements (such as IS<italic>1002</italic>), SNPs, premature stop codons and various deletions [<xref rid="R21" ref-type="bibr">21, 32, 70, 72</xref>], Prn<sup>&#x02212;</sup> strains fail to fully outcompete Prn<sup>+</sup> isolates. As a case in point, only a single Prn<sup>&#x02212;</sup> strain has been identified in a recent study that analysed 95 isolates harvested mostly between 2000 and 2012 in the UK, a country that switched from WCV to ACV for primary immunizations in October 2004 [<xref rid="R25" ref-type="bibr">25, 73</xref>]. Therefore, pertactin deficiency in itself, while perhaps initially providing an evolutionary benefit, may not carry sufficient advantages to eradicate other <italic>B. pertussis</italic> isolates, particularly those with a non-vaccine-type <italic>prn</italic> allele, e.g. <italic>prn2</italic>, and/or increased pertussis toxin production afforded by the <italic>ptxP3</italic> mutation.</p></sec><sec id="s2-6-5"><title>Gene variants and SNPs present in isolates with disrupting mutations in the pertactin gene</title><p>Genome-wide comparison of gene variants in Prn<sup>+</sup> and Prn<sup>&#x02212;</sup> isolates identified several gene differences present in isolates without functional pertactin. The majority of these associations probably represent hitchhiking mutations that occurred during acquisition of pertactin deficiency, and were clonally retained. Among gene variants, the most significant association was detected for an 11&#x02009;bp deletion in gene <italic>BP0310</italic> (position 315&#x0200a;417&#x02013;315&#x0200a;427 in the genome of strain Tohama I), encoding a putative acyl-CoA-dehydrogenase, resulting in a truncated protein (data not shown). This variant was absent from the <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic> isolates and from the vast majority of Prn<sup>+</sup> strains but was found in all <italic>prn</italic>&#x00394;SS isolates and in only four Prn<sup>+</sup> isolates (BP1, BP9, BP61 and BP156). The latter four isolates cluster with the <italic>prn</italic>&#x00394;SS isolates on the phylogenetic tree, perhaps indicating that this deletion preceded the deletion of the signal sequence in <italic>prn</italic>.</p><p>Table S4 shows all SNPs identified in this study among all 188 isolates, compared to strain Tohama I, and Table S5 illustrates the results of an analysis of SNP differences between Prn<sup>+</sup> and Prn<sup>&#x02212;</sup> strains of the <italic>ptxA2&#x0200a;:&#x0200a;ptxP1&#x0200a;:&#x0200a;prn1</italic> clade. We identified a non-synonymous SNP present exclusively and consistently in all <italic>prn</italic>&#x00394;SS strains in gene <italic>BP0534</italic>, encoding a putative enoyl-CoA hydratase/isomerase. No SNPs were found that were present in all <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic> Prn<sup>&#x02212;</sup> isolates but not in Prn<sup>+</sup>
<italic>ptxA2&#x0200a;:&#x0200a;ptxP1&#x0200a;:&#x0200a;prn1</italic> isolates. However, SNPs in <italic>BP0332</italic> and <italic>BP1640</italic>, both encoding proteins of unknown function, were detected in all but one <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic> Prn<sup>&#x02212;</sup> isolate, and nowhere else. The <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic> Prn<sup>&#x02212;</sup> isolate lacking this SNP was BP118, a strain that clustered separately from all other <italic>prn&#x0200a;</italic>::&#x0200a;IS<italic>481</italic> isolates on the phylogenetic trees depicted in <xref ref-type="fig" rid="F1 F3">Figs 1 and 3</xref>. The functional effects of the detected SNPs and gene variants on bacterial pathogenicity, growth and fitness are unknown but may be verified with additional future experiments.</p></sec><sec id="s2-6-6"><title>Local <italic>B. pertussis</italic> population dynamics may differ profoundly from national trends</title><p>The 38 strains that contained a deletion of the signal sequence of the pertactin gene were deficient in pertactin production and clustered together on the phylogenetic tree, indicating a clonal spread of the isolate. These strains had been harvested over the course of 13&#x02009;years, between 2000 and 2013. A total of 18 of these strains had been provided by the Konan Kosei Hospital. Among all <italic>B. pertussis</italic> isolates reported in this hospital, prevalence of this clone reached over 90&#x0200a;% in 2008 and 100&#x0200a;% in 2009, while, according to our strain panel, the same clone represented only around 16&#x0200a;% of <italic>B. pertussis</italic> isolates found in the rest of the country at that time. After 2009, the isolate&#x02019;s prevalence in Konan fell back to approximately national levels. This observation suggests that this particular <italic>prn</italic>&#x00394;SS isolate prevailed and persisted over at least 2 years within the Konan community. It is therefore likely that the overall fitness of this strain was at least as good as that of standard Prn<sup>+</sup> isolates that existed in the vaccinated population of Konan at the same time.</p></sec><sec id="s2-6-7"><title>Rates of genetic variants</title><p>We performed an examination of the rates of genetic variants (nucleotide variant rates per base pair) observed in the core genome among the sequenced <italic>B. pertussis</italic> isolates from Japan. Table S6 shows all variation rates for each <italic>B. pertussis</italic> Tohama I gene included in the core genome. The analysis confirmed a higher overall rate of variants for the nine genes predicted to encode ACV-targeted proteins (<italic>fhaB</italic>, <italic>fim2</italic>, <italic>fim3</italic>, <italic>prn</italic>, <italic>ptxA&#x02013;E</italic>), compared to all genes (0.0014 versus 0.0006 variants/bp). A summary of the observed overall rates and the amino-acid-changing rates for the functional categories of the <italic>B. pertussis</italic> Tohama I core genes is depicted in <xref ref-type="table" rid="T2">Table 2</xref>. The analysis suggests that genes targeted by ACVs do indeed mutate more frequently than coding sequences in most other gene categories, an effect that had been previously described [<xref rid="R25" ref-type="bibr">25</xref>]. They also mutate, on average, more frequently than genes encoding proteins predicted to be located extracellularly (20 genes, 0.0006 variants/bp) or in the outer membrane (70 genes, 0.0010 variants/bp). In contrast to previous observations [<xref rid="R16" ref-type="bibr">16</xref>], this trend of elevated mutation frequency does not extend to a similar degree from the ACV genes to other virulence-associated genes in our strain panel. Perhaps this can be explained in part by the early adoption of ACVs in Japan, thereby focusing pressures onto the vaccine-targeted proteins earlier than in other countries.</p><table-wrap id="T2" position="float"><label>Table 2.</label><caption><title>Rates of genetic variants observed in functional gene categories in Japanese <italic>B. pertussis</italic> isolates</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Functional category*</th><th align="left" rowspan="1" colspan="1">Number of genes</th><th align="left" rowspan="1" colspan="1">Median gene length</th><th align="left" rowspan="1" colspan="1">Non-silent variant rate&#x02020;</th><th align="left" rowspan="1" colspan="1">Total variant rate&#x02021;</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Fatty acid metabolism</td><td align="char" char="." rowspan="1" colspan="1">21</td><td align="char" char="." rowspan="1" colspan="1">936</td><td align="char" char="." rowspan="1" colspan="1">0.0002</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td></tr><tr><td align="left" rowspan="1" colspan="1">Small molecule degradation</td><td align="char" char="." rowspan="1" colspan="1">107</td><td align="char" char="." rowspan="1" colspan="1">1068</td><td align="char" char="." rowspan="1" colspan="1">0.0003</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td></tr><tr><td align="left" rowspan="1" colspan="1">Macromolecule degradation</td><td align="char" char="." rowspan="1" colspan="1">46</td><td align="char" char="." rowspan="1" colspan="1">1234.5</td><td align="char" char="." rowspan="1" colspan="1">0.0003</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell division</td><td align="char" char="." rowspan="1" colspan="1">18</td><td align="char" char="." rowspan="1" colspan="1">1014</td><td align="char" char="." rowspan="1" colspan="1">0.0003</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td></tr><tr><td align="left" rowspan="1" colspan="1">Ribonucleotide biosynthesis</td><td align="char" char="." rowspan="1" colspan="1">27</td><td align="char" char="." rowspan="1" colspan="1">1080</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td></tr><tr><td align="left" rowspan="1" colspan="1">Macromolecule synthesis/modification</td><td align="char" char="." rowspan="1" colspan="1">194</td><td align="char" char="." rowspan="1" colspan="1">1068</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell processes</td><td align="char" char="." rowspan="1" colspan="1">62</td><td align="char" char="." rowspan="1" colspan="1">927</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td></tr><tr><td align="left" rowspan="1" colspan="1">Cofactor biosynthesis</td><td align="char" char="." rowspan="1" colspan="1">86</td><td align="char" char="." rowspan="1" colspan="1">846</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td></tr><tr><td align="left" rowspan="1" colspan="1">Ribosome constituents</td><td align="char" char="." rowspan="1" colspan="1">55</td><td align="char" char="." rowspan="1" colspan="1">384</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td></tr><tr><td align="left" rowspan="1" colspan="1">Amino acid biosynthesis</td><td align="char" char="." rowspan="1" colspan="1">91</td><td align="char" char="." rowspan="1" colspan="1">1134</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td></tr><tr><td align="left" rowspan="1" colspan="1">Adaptation</td><td align="char" char="." rowspan="1" colspan="1">48</td><td align="char" char="." rowspan="1" colspan="1">563.5</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td></tr><tr><td align="left" rowspan="1" colspan="1">Central/intermediary metabolism</td><td align="char" char="." rowspan="1" colspan="1">96</td><td align="char" char="." rowspan="1" colspan="1">1016.5</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td></tr><tr><td align="left" rowspan="1" colspan="1">Energy metabolism</td><td align="char" char="." rowspan="1" colspan="1">119</td><td align="char" char="." rowspan="1" colspan="1">1056</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td></tr><tr><td align="left" rowspan="1" colspan="1">Transport/binding proteins</td><td align="char" char="." rowspan="1" colspan="1">326</td><td align="char" char="." rowspan="1" colspan="1">970.5</td><td align="char" char="." rowspan="1" colspan="1">0.0004</td><td align="char" char="." rowspan="1" colspan="1">0.0006</td></tr><tr><td align="left" rowspan="1" colspan="1">Miscellaneous</td><td align="char" char="." rowspan="1" colspan="1">342</td><td align="char" char="." rowspan="1" colspan="1">886.5</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td><td align="char" char="." rowspan="1" colspan="1">0.0006</td></tr><tr><td align="left" rowspan="1" colspan="1">Conserved hypothetical</td><td align="char" char="." rowspan="1" colspan="1">419</td><td align="char" char="." rowspan="1" colspan="1">681</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td><td align="char" char="." rowspan="1" colspan="1">0.0006</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell surface</td><td align="char" char="." rowspan="1" colspan="1">571</td><td align="char" char="." rowspan="1" colspan="1">951</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td><td align="char" char="." rowspan="1" colspan="1">0.0006</td></tr><tr><td align="left" rowspan="1" colspan="1">Protection responses</td><td align="char" char="." rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">639</td><td align="char" char="." rowspan="1" colspan="1">0.0006</td><td align="char" char="." rowspan="1" colspan="1">0.0006</td></tr><tr><td align="left" rowspan="1" colspan="1">Regulation</td><td align="char" char="." rowspan="1" colspan="1">270</td><td align="char" char="." rowspan="1" colspan="1">829.5</td><td align="char" char="." rowspan="1" colspan="1">0.0007</td><td align="char" char="." rowspan="1" colspan="1">0.0008</td></tr><tr><td align="left" rowspan="1" colspan="1">Virulence-associated genes</td><td align="char" char="." rowspan="1" colspan="1">89</td><td align="char" char="." rowspan="1" colspan="1">1095</td><td align="char" char="." rowspan="1" colspan="1">0.0007</td><td align="char" char="." rowspan="1" colspan="1">0.0009</td></tr><tr><td align="left" rowspan="1" colspan="1">Unknown</td><td align="char" char="." rowspan="1" colspan="1">134</td><td align="char" char="." rowspan="1" colspan="1">463.5</td><td align="char" char="." rowspan="1" colspan="1">0.0008</td><td align="char" char="." rowspan="1" colspan="1">0.0010</td></tr><tr><td align="left" rowspan="1" colspan="1">ACV genes</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">681</td><td align="char" char="." rowspan="1" colspan="1">0.0012</td><td align="char" char="." rowspan="1" colspan="1">0.0014</td></tr><tr><td align="left" rowspan="1" colspan="1">Phage-related or transposon-related</td><td align="char" char="." rowspan="1" colspan="1">21</td><td align="char" char="." rowspan="1" colspan="1">648</td><td align="char" char="." rowspan="1" colspan="1">0.0013</td><td align="char" char="." rowspan="1" colspan="1">0.0016</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>All genes</bold></td><td align="char" char="." rowspan="1" colspan="1">3168</td><td align="char" char="." rowspan="1" colspan="1">879</td><td align="char" char="." rowspan="1" colspan="1">0.0005</td><td align="char" char="." rowspan="1" colspan="1">0.0006</td></tr></tbody></table><table-wrap-foot><fn id="tblfn3"><p id="t2_1">*Functional categories are from a previous source [<xref rid="R16" ref-type="bibr">16</xref>].</p></fn><fn id="tblfn4"><p id="t2_2">&#x02020;The variant rate was calculated as (sum of amino acid-changing variants of genes in category &#x02013; number of genes in category)/(sum of gene length of all genes in category, in bp).</p></fn><fn id="tblfn5"><p id="t2_3">&#x02021;The variant rate was calculated as (sum of nucleotide variants of genes in category &#x02013; number of genes in category)/(sum of gene length of all genes in category, in bp).</p></fn></table-wrap-foot></table-wrap><p>A number of genes encoding proteins that localize close to the bacterial surface, or whose localization has not been characterized in detail as yet, display a higher than average genetic variation rate, suggesting that these may have experienced high antigenic pressure. Among the 15 genes that encode seven or more amino acid variants in our strain panel were <italic>fhaB</italic> (11 variants) and two autotransporters, <italic>tcfA</italic> (seven variants) and <italic>sphB2</italic> (31 variants). Further investigation may be warranted to better understand the observed sequence variation in these genes.</p><p>The genetic variant analysis also revealed 33 outer membrane proteins, 17 of which are known to be under Bvg control, which displayed only one genetic variant in the 188 Japanese strains (Table S6). These proteins may be of some interest for future strategies to combat pertussis, although strong sequence conservation may be indicative of low immune pressure. Among these are components of several TonB-dependent iron uptake systems, including the putative haem receptor HemC and putative ferric siderophore receptors encoded by the <italic>bfr</italic> operon [<xref rid="R74" ref-type="bibr">74</xref>]. The protein that suppresses the bactericidal activity of the complement, BrkA [<xref rid="R75" ref-type="bibr">75</xref>], and the putative fimbrial usher protein FimC [<xref rid="R76" ref-type="bibr">76</xref>] were also among the gene products with no observed variations. Seven of these genes, including <italic>bfrH</italic> and the gene encoding the outer membrane protein OmpA, were also conserved in 343 worldwide strains [<xref rid="R16" ref-type="bibr">16</xref>].</p><p>A normalized comparison of previously reported SNP densities from isolates stemming predominantly from the WCV era [<xref rid="R16" ref-type="bibr">16</xref>] with the ACV-era variant rates observed in the Japanese strain panel did not reveal significant differences in the propensity for genetic variation in the nine genes encoding ACV-targeted proteins (data not shown).</p></sec><sec id="s2-6-8"><title>Temporal fluctuations of the <italic>B. pertussis</italic> population size in Japan</title><p>Based on the molecular clock data analysis as determined by <sc>beast</sc>, fluctuations in the <italic>B. pertussis</italic> effective population size per year relative to the sample data were inferred from the fluctuations in the number of mutations in the <italic>B. pertussis</italic> genomes sequenced. For this analysis, the isolates obtained from Konan Kosei Hospital were excluded. As illustrated in <xref ref-type="fig" rid="F4">Fig. 4</xref>, two increases in effective population size were predicted between 1950 and 2012 &#x02013; one around 1974, and another increase in the mid-1990s. The first increase coincides with a public debate on vaccine safety following two infant deaths within 24&#x02009;h after WCV administration in the winter of 1974/75, which led to a 2-month temporary suspension of the use of the vaccine and a subsequent raise in age from 3&#x02009;months to 2&#x02009;years at which the primary vaccine dose was to be administrated [<xref rid="R77" ref-type="bibr">77</xref>]. These events may explain the inferred increase in <italic>B. pertussis</italic> population size. The second increase coincides with a change in the Preventive Vaccination Law in 1994 in Japan where mass vaccination in regional Public Health Centers was replaced by individual private inoculation upon recommendation, while at the same time the recommended age for the primary series of ACV inoculation was changed from 2&#x02009;years back to 3&#x02013;12&#x02009;months [<xref rid="R78" ref-type="bibr">78, 79</xref>]. Consistent with our prediction of an increased <italic>B. pertussis</italic> population size in Japan after temporary cessation and/or a lower vaccination rate, previous studies have detected the reverse effect on population diversity after introduction of vaccine programmes [<xref rid="R73" ref-type="bibr">73, 80, 81</xref>]. However, because genome sequencing has higher resolution than the typing methods employed in those studies, the magnitudes of these effects are difficult to compare.</p><fig id="F4" fig-type="figure" position="float"><label>Fig. 4.</label><caption><p>Bayesian Skyline Plot of <italic>B. pertussis</italic> in Japan, excluding Konan Kosei isolates. Fluctuations in the <italic>B. pertussis</italic> effective population size per year relative to the sample data were inferred from the fluctuations in the number of mutations in the <italic>B. pertussis</italic> genomes sequenced. The 95&#x0200a;% CIs are in blue. The predictions are based on the molecular clock data analysis as determined by <sc>beast</sc> (see Methods). Coinciding events that may affect population size are marked by arrows.</p></caption><graphic xlink:href="mgen-4-180-g004"/></fig><p>Notably, despite the <sc>beast</sc>-predicted increase and subsequent stabilization of the effective population size of <italic>B. pertussis</italic> in the mid-1990s in Japan, the actual case numbers reported to the NIID declined in the late 1990s [<xref rid="R82" ref-type="bibr">82, 83</xref>]. ACVs may therefore effectively protect against developing pertussis disease, but may not prevent asymptomatic carriage and circulation of the bacterial strains, as observed in vaccination studies in baboons [<xref rid="R13" ref-type="bibr">13</xref>].</p><p>In Japan, as in other parts of the world, pertussis has experienced a worldwide resurgence that cannot be attributed to lower vaccine coverage alone. The rising percentage of pertussis cases in Japanese teenagers or adults [<xref rid="R84" ref-type="bibr">84</xref>] suggests waning immunity to be one contributing factor, coupled with a vaccination schedule that incorporates a booster at an early age (2&#x02009;years) but lacks a secondary immunization for adolescents, as championed in the USA [<xref rid="R2" ref-type="bibr">2</xref>]. Recent studies revealed that the level of decrease in vaccine effectiveness against pertussis disease depends on both the specific vaccine antigen and the subject&#x02019;s age [<xref rid="R85" ref-type="bibr">85</xref>]. As a short-term solution, the efficacy of existing vaccines may be improved by a change in vaccination booster regimens, by an expansion of maternal immunizations or by improving existing ACV antigens. However, novel targets for future ACV approaches, including a potential change in adjuvants, may be desirable [<xref rid="R86" ref-type="bibr">86, 87</xref>].</p></sec></sec><sec id="s1-7"><title>Conclusions</title><p>A focused genome analysis of almost 200 <italic>B. pertussis</italic> strains prevalent in the last 35&#x02009;years in Japan revealed the existence of two major phylogenetic clades that coexist in the country. A shift in the population occurred in the past 10 years where isolates of the clade characterized by the <italic>ptxA1&#x0200a;:&#x0200a;ptxP3&#x0200a;:&#x0200a;prn2</italic> genotype began to dominate the <italic>B. pertussis</italic> population in Japan over isolates of the <italic>ptxA2&#x0200a;:&#x0200a;ptxP1&#x0200a;:&#x0200a;prn1</italic> genotype. This shift coincides with an increase in pertussis cases in the country.</p><p>Despite a lack of evidence for a direct effect of ACVs on the genotype shift of the <italic>B. pertussis</italic> population in Japan, this study noted a high rate of genetic variants for the genes targeted in the current ACV preparations, compared with other cell surface proteins. This observation confirms a certain degree of selective evolutionary pressure exerted by the ACVs.</p><p>Pertactin deficiency appeared around 1990 on at least two separate occasions, and probably again in the mid-1990s, in Japan, after ACVs had been adopted. Pertactin-deficient <italic>prn1</italic> isolates continue to be observed in Japan, although with decreasing prevalence since 2005.</p><p>Genetic variant analysis revealed a number of candidate proteins that are part of the <italic>B. pertussis</italic> core genome and may resist genetic variation, a subset of which consists of outer membrane proteins. In addition, several genes were identified that have a relatively high variant frequency, perhaps suggesting good antigenic properties. Such information may help in selecting candidate targets for a more effective pertussis vaccine.</p></sec><sec id="s1-8"><title>Data bibliography</title><list list-type="order"><list-item><p>Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, <italic>et al.</italic> ENA SRA PRJEB2274 (2015).</p></list-item></list></sec></body><back><ack id="ack1"><title>Funding information</title><p>Writing and editorial support was funded by Janssen Vaccines and Prevention B.V. and provided by APEX Think Corporation, Fallbrook, CA, USA.</p></ack><ack id="ack2"><title>Conflicts of interest</title><p content-type="COI-statement">AZ is an employee of Utrecht University, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, in Utrecht, the Netherlands, providing services for Janssen Vaccines and Prevention B.V., Leiden, the Netherlands. JP and JG are employees of Janssen Vaccines and Prevention B.V. (former Crucell Holland B.V.), part of the Janssen Pharmaceutical Companies of Johnson and Johnson, Department of Bacterial Vaccines Discovery and Early Development, in Leiden, the Netherlands. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in this paper, apart from those disclosed.</p></ack><ack id="ack3"><title>Acknowledgements</title><p>The authors acknowledge the contribution of Tomomi Kimura, Peter Hermans, Selma Wiertsema and Sander Fortanier for supporting the initiation and execution of the study.</p></ack><fn-group><fn id="FN1"><p>Abbreviations: ACV, acellular vaccine; IS, insertion sequence; NIID, National Institute of Infectious Diseases, Japan; OG, orthologous group; Prn, pertactin; SS, signal sequence; WCV, whole-cell vaccine; CI, confidence interval.</p></fn><fn id="FN2"><p>All supporting data, code and protocols have been provided within the article or through supplementary data files. Six supplementary tables are available with the online version of this article.</p></fn></fn-group><app-group><app content-type="supplementary-data"><title>Supplementary Data</title><supplementary-material content-type="local-data" id="supp1"><object-id pub-id-type="file-size">2370</object-id><caption><title>Supplementary File 1</title></caption><media xlink:href="mgen-4-180-s001.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>CDC</collab></person-group><year>2015</year><article-title>Epidemiology and Prevention of Vaccine-Preventable Diseases</article-title><ext-link ext-link-type="uri" xlink:href="www.cdc.gov/vaccines/pubs/pinkbook/pert.html#vaccines">www.cdc.gov/vaccines/pubs/pinkbook/pert.html#vaccines</ext-link><comment>accessed 10/03/2016</comment></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Nagai</surname><given-names>M</given-names></name></person-group><article-title>Acellular pertussis vaccines in Japan: past, present and future</article-title><source>Expert Rev Vaccines</source><year>2005</year><volume>4</volume><fpage>173</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1586/14760584.4.2.173</pub-id><pub-id pub-id-type="pmid">15889991</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Fukumi</surname><given-names>H</given-names></name></person-group><article-title>Development of a pertussis component vaccine in Japan</article-title><source>Lancet</source><year>1984</year><volume>323</volume><fpage>122</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(84)90061-8</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>T</given-names></name></person-group><article-title>Pertussis vaccine in Japan</article-title><source>J Infect Chemother</source><year>1999</year><volume>5</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1007/s101560050032</pub-id><pub-id pub-id-type="pmid">11810514</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuno-Sakai</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name></person-group><article-title>Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23&#x02003;years of its use for routine immunization</article-title><source>Pediatrics International</source><year>2004</year><volume>46</volume><fpage>650</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1111/j.1442-200x.2004.01970.x</pub-id><pub-id pub-id-type="pmid">15660862</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name></person-group><article-title>Development of acellular pertussis vaccines</article-title><source>Biologicals</source><year>1999</year><volume>27</volume><fpage>61</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1006/biol.1999.0181</pub-id><pub-id pub-id-type="pmid">10600185</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>M</given-names></name><name><surname>Fukuoka</surname><given-names>M</given-names></name><name><surname>Tashiro</surname><given-names>K</given-names></name><name><surname>Ozaki</surname><given-names>I</given-names></name><name><surname>Ohfuji</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan</article-title><source>BMC Infect Dis</source><year>2015</year><volume>15</volume><fpage>45</fpage><pub-id pub-id-type="doi">10.1186/s12879-015-0777-3</pub-id><pub-id pub-id-type="pmid">25656486</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horiba</surname><given-names>K</given-names></name><name><surname>Nishimura</surname><given-names>N</given-names></name><name><surname>Gotoh</surname><given-names>K</given-names></name><name><surname>Kawaguchi</surname><given-names>M</given-names></name><name><surname>Takeuchi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Clinical manifestations of children with microbiologically confirmed pertussis infection and antimicrobial susceptibility of isolated strains in a regional hospital in Japan, 2008&#x02013;2012</article-title><source>Jpn J Infect Dis</source><year>2014</year><volume>67</volume><fpage>345</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.7883/yoken.67.345</pub-id><pub-id pub-id-type="pmid">25241683</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooi</surname><given-names>FR</given-names></name><name><surname>van der Maas</surname><given-names>NAT</given-names></name><name><surname>de Melker</surname><given-names>HE</given-names></name></person-group><article-title>Pertussis resurgence: waning immunity and pathogen adaptation &#x02013; two sides of the same coin</article-title><source>Epidemiol Infect</source><year>2014</year><volume>142</volume><fpage>685</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1017/S0950268813000071</pub-id><pub-id pub-id-type="pmid">23406868</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>SL</given-names></name><name><surname>Frith</surname><given-names>K</given-names></name><name><surname>Snelling</surname><given-names>TL</given-names></name><name><surname>Grimwood</surname><given-names>K</given-names></name><name><surname>McIntyre</surname><given-names>PB</given-names></name><etal/></person-group><article-title>Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology</article-title><source>Expert Rev Vaccines</source><year>2014</year><volume>13</volume><fpage>1081</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.1586/14760584.2014.944167</pub-id><pub-id pub-id-type="pmid">25093268</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>NP</given-names></name><name><surname>Bartlett</surname><given-names>J</given-names></name><name><surname>Fireman</surname><given-names>B</given-names></name><name><surname>Aukes</surname><given-names>L</given-names></name><name><surname>Buck</surname><given-names>PO</given-names></name><etal/></person-group><article-title>Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine</article-title><source>Vaccine</source><year>2017</year><volume>35</volume><fpage>3395</fpage><lpage>3400</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2017.05.008</pub-id><pub-id pub-id-type="pmid">28506516</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Mertsola</surname><given-names>J</given-names></name></person-group><article-title>Factors contributing to pertussis resurgence</article-title><source>Future Microbiol</source><year>2008</year><volume>3</volume><fpage>329</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.2217/17460913.3.3.329</pub-id><pub-id pub-id-type="pmid">18505398</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warfel</surname><given-names>JM</given-names></name><name><surname>Zimmerman</surname><given-names>LI</given-names></name><name><surname>Merkel</surname><given-names>TJ</given-names></name></person-group><article-title>Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model</article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><fpage>787</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1073/pnas.1314688110</pub-id><pub-id pub-id-type="pmid">24277828</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warfel</surname><given-names>JM</given-names></name><name><surname>Zimmerman</surname><given-names>LI</given-names></name><name><surname>Merkel</surname><given-names>TJ</given-names></name></person-group><article-title>Comparison of three whole-cell pertussis vaccines in the baboon model of pertussis</article-title><source>Clin Vaccine Immunol</source><year>2016</year><volume>23</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1128/CVI.00449-15</pub-id><pub-id pub-id-type="pmid">26561389</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooi</surname><given-names>FR</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>van Oirschot</surname><given-names>H</given-names></name><name><surname>Mertsola</surname><given-names>J</given-names></name></person-group><article-title>Variation in the <italic>Bordetella pertussis</italic> virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland</article-title><source>Infect Immun</source><year>1999</year><volume>67</volume><fpage>3133</fpage><lpage>3134</lpage><pub-id pub-id-type="pmid">10338531</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bart</surname><given-names>MJ</given-names></name><name><surname>Harris</surname><given-names>SR</given-names></name><name><surname>Advani</surname><given-names>A</given-names></name><name><surname>Arakawa</surname><given-names>Y</given-names></name><name><surname>Bottero</surname><given-names>D</given-names></name><etal/></person-group><article-title>Global population structure and evolution of <italic>Bordetella pertussis</italic> and their relationship with vaccination</article-title><source>MBio</source><year>2014</year><volume>5</volume><elocation-id>e01074</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01074-14</pub-id><pub-id pub-id-type="pmid">24757216</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooi</surname><given-names>FR</given-names></name><name><surname>van Oirschot</surname><given-names>H</given-names></name><name><surname>Heuvelman</surname><given-names>K</given-names></name><name><surname>van der Heide</surname><given-names>HG</given-names></name><name><surname>Gaastra</surname><given-names>W</given-names></name><etal/></person-group><article-title>Polymorphism in the <italic>Bordetella pertussis</italic> virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution</article-title><source>Infect Immun</source><year>1998</year><volume>66</volume><fpage>670</fpage><lpage>675</lpage><pub-id pub-id-type="pmid">9453625</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooi</surname><given-names>FR</given-names></name><name><surname>van Loo</surname><given-names>IHM</given-names></name><name><surname>van Gent</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Bart</surname><given-names>MJ</given-names></name><etal/></person-group><article-title><italic>Bordetella pertussis</italic> strains with increased toxin production associated with pertussis resurgence</article-title><source>Emerg Infect Dis</source><year>2009</year><volume>15</volume><fpage>1206</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.3201/eid1508.081511</pub-id><pub-id pub-id-type="pmid">19751581</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loconsole</surname><given-names>D</given-names></name><name><surname>de Robertis</surname><given-names>AL</given-names></name><name><surname>Morea</surname><given-names>A</given-names></name><name><surname>Metallo</surname><given-names>A</given-names></name><name><surname>Lopalco</surname><given-names>PL</given-names></name><etal/></person-group><article-title>Resurgence of pertussis and emergence of the <italic>Ptxp3</italic> toxin promoter allele in South Italy</article-title><source>Pediatr Infect Dis J</source><year>2018</year><volume>37</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1097/INF.0000000000001804</pub-id><pub-id pub-id-type="pmid">28719497</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Octavia</surname><given-names>S</given-names></name><name><surname>Sintchenko</surname><given-names>V</given-names></name><name><surname>Gilbert</surname><given-names>GL</given-names></name><name><surname>Lawrence</surname><given-names>A</given-names></name><name><surname>Keil</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Newly emerging clones of <italic>Bordetella pertussis</italic> carrying <italic>prn2</italic> and <italic>ptxP3</italic> alleles implicated in Australian pertussis epidemic in 2008&#x02013;2010</article-title><source>J Infect Dis</source><year>2012</year><volume>205</volume><fpage>1220</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis178</pub-id><pub-id pub-id-type="pmid">22416243</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawloski</surname><given-names>LC</given-names></name><name><surname>Queenan</surname><given-names>AM</given-names></name><name><surname>Cassiday</surname><given-names>PK</given-names></name><name><surname>Lynch</surname><given-names>AS</given-names></name><name><surname>Harrison</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Prevalence and molecular characterization of pertactin-deficient <italic>Bordetella pertussis</italic> in the United States</article-title><source>Clin Vaccine Immunol</source><year>2014</year><volume>21</volume><fpage>119</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1128/CVI.00717-13</pub-id><pub-id pub-id-type="pmid">24256623</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuel</surname><given-names>M</given-names></name><name><surname>Jamieson</surname><given-names>FB</given-names></name><name><surname>Tang</surname><given-names>P</given-names></name><name><surname>Brown</surname><given-names>S</given-names></name><name><surname>Farrell</surname><given-names>D</given-names></name><etal/></person-group><article-title>Genetic analysis of <italic>Bordetella pertussis</italic> in Ontario, Canada reveals one predominant clone</article-title><source>Int J Infect Dis</source><year>2013</year><volume>17</volume><elocation-id>e413</elocation-id><lpage>e417</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2012.12.015</pub-id><pub-id pub-id-type="pmid">23352492</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kodama</surname><given-names>A</given-names></name><name><surname>Kamachi</surname><given-names>K</given-names></name><name><surname>Horiuchi</surname><given-names>Y</given-names></name><name><surname>Konda</surname><given-names>T</given-names></name><name><surname>Arakawa</surname><given-names>Y</given-names></name></person-group><article-title>Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of <italic>Bordetella pertussis</italic> isolates in Japan</article-title><source>J Clin Microbiol</source><year>2004</year><volume>42</volume><fpage>5453</fpage><lpage>5457</lpage><pub-id pub-id-type="doi">10.1128/JCM.42.12.5453-5457.2004</pub-id><pub-id pub-id-type="pmid">15583264</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidtke</surname><given-names>AJ</given-names></name><name><surname>Boney</surname><given-names>KO</given-names></name><name><surname>Martin</surname><given-names>SW</given-names></name><name><surname>Skoff</surname><given-names>TH</given-names></name><name><surname>Tondella</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Population diversity among <italic>Bordetella pertussis</italic> isolates, United States, 1935&#x02013;2009</article-title><source>Emerg Infect Dis</source><year>2012</year><volume>18</volume><fpage>1248</fpage><lpage>1255</lpage><pub-id pub-id-type="doi">10.3201/eid1808.120082</pub-id><pub-id pub-id-type="pmid">22841154</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sealey</surname><given-names>KL</given-names></name><name><surname>Harris</surname><given-names>SR</given-names></name><name><surname>Fry</surname><given-names>NK</given-names></name><name><surname>Hurst</surname><given-names>LD</given-names></name><name><surname>Gorringe</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving</article-title><source>J Infect Dis</source><year>2015</year><volume>212</volume><fpage>294</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiu665</pub-id><pub-id pub-id-type="pmid">25489002</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gent</surname><given-names>M</given-names></name><name><surname>Bart</surname><given-names>MJ</given-names></name><name><surname>van der Heide</surname><given-names>HGJ</given-names></name><name><surname>Heuvelman</surname><given-names>KJ</given-names></name><name><surname>Mooi</surname><given-names>FR</given-names></name></person-group><article-title>Small mutations in <italic>Bordetella pertussis</italic> are associated with selective sweeps</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><elocation-id>e46407</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0046407</pub-id><pub-id pub-id-type="pmid">23029513</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>B</given-names></name><name><surname>Melzer</surname><given-names>H</given-names></name><name><surname>Freym&#x000fc;ller</surname><given-names>G</given-names></name><name><surname>Stumvoll</surname><given-names>S</given-names></name><name><surname>Rendi-Wagner</surname><given-names>P</given-names></name><etal/></person-group><article-title>Genetic variation of <italic>Bordetella pertussis</italic> in Austria</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><elocation-id>e0132623</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0132623</pub-id><pub-id pub-id-type="pmid">26182210</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkoff</surname><given-names>A-M</given-names></name><name><surname>Mertsola</surname><given-names>J</given-names></name><name><surname>Guillot</surname><given-names>S</given-names></name><name><surname>Guiso</surname><given-names>N</given-names></name><name><surname>Berbers</surname><given-names>G</given-names></name><etal/></person-group><article-title>Appearance of <italic>Bordetella pertussis</italic> strains not expressing the vaccine antigen pertactin in Finland</article-title><source>Clin Vaccine Immunol</source><year>2012</year><volume>19</volume><fpage>1703</fpage><lpage>1704</lpage><pub-id pub-id-type="doi">10.1128/CVI.00367-12</pub-id><pub-id pub-id-type="pmid">22914363</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegerle</surname><given-names>N</given-names></name><name><surname>Paris</surname><given-names>A-S</given-names></name><name><surname>Brun</surname><given-names>D</given-names></name><name><surname>Dore</surname><given-names>G</given-names></name><name><surname>Njamkepo</surname><given-names>E</given-names></name><etal/></person-group><article-title>Evolution of French <italic>Bordetella pertussis</italic> and <italic>Bordetella parapertussis</italic> isolates: increase of <italic>Bordetellae</italic> not expressing pertactin</article-title><source>Clin Microbiol Infect</source><year>2012</year><volume>18</volume><elocation-id>E340</elocation-id><lpage>E346</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2012.03925.x</pub-id><pub-id pub-id-type="pmid">22717007</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Queenan</surname><given-names>AM</given-names></name><name><surname>Cassiday</surname><given-names>PK</given-names></name><name><surname>Evangelista</surname><given-names>A</given-names></name></person-group><article-title>Pertactin-negative variants of <italic>Bordetella pertussis</italic> in the United States</article-title><source>N Engl J Med Overseas Ed</source><year>2013</year><volume>368</volume><fpage>583</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1209369</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>KE</given-names></name><name><surname>Williams</surname><given-names>MM</given-names></name><name><surname>Cassiday</surname><given-names>PK</given-names></name><name><surname>Milton</surname><given-names>A</given-names></name><name><surname>Pawloski</surname><given-names>L</given-names></name><etal/></person-group><article-title>Molecular epidemiology of the pertussis epidemic in Washington State in 2012</article-title><source>J Clin Microbiol</source><year>2014</year><volume>52</volume><fpage>3549</fpage><lpage>3557</lpage><pub-id pub-id-type="doi">10.1128/JCM.01189-14</pub-id><pub-id pub-id-type="pmid">25031439</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>C</given-names></name><name><surname>Octavia</surname><given-names>S</given-names></name><name><surname>Ricafort</surname><given-names>L</given-names></name><name><surname>Sintchenko</surname><given-names>V</given-names></name><name><surname>Gilbert</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Rapid increase in pertactin-deficient <italic>Bordetella pertussis</italic> isolates, Australia</article-title><source>Emerg Infect Dis</source><year>2014</year><volume>20</volume><fpage>626</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.3201/eid2004.131478</pub-id><pub-id pub-id-type="pmid">24655754</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>SW</given-names></name><name><surname>Pawloski</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>M</given-names></name><name><surname>Weening</surname><given-names>K</given-names></name><name><surname>Debolt</surname><given-names>C</given-names></name><etal/></person-group><article-title>Pertactin-negative <italic>Bordetella pertussis</italic> strains: evidence for a possible selective advantage</article-title><source>Clin Infect Dis</source><year>2015</year><volume>60</volume><fpage>223</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1093/cid/ciu788</pub-id><pub-id pub-id-type="pmid">25301209</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>T</given-names></name><name><surname>Musser</surname><given-names>KA</given-names></name><name><surname>Currenti</surname><given-names>SA</given-names></name><name><surname>Zansky</surname><given-names>SM</given-names></name><name><surname>Halse</surname><given-names>TA</given-names></name></person-group><article-title>Pertactin-negative variants of <italic>Bordetella pertussis</italic> in New York State: a retrospective analysis, 2004&#x02013;2013</article-title><source>Mol Cell Probes</source><year>2014</year><volume>28</volume><fpage>138</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.mcp.2013.12.003</pub-id><pub-id pub-id-type="pmid">24365130</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeddeman</surname><given-names>A</given-names></name><name><surname>van Gent</surname><given-names>M</given-names></name><name><surname>Heuvelman</surname><given-names>CJ</given-names></name><name><surname>van der Heide</surname><given-names>HG</given-names></name><name><surname>Bart</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Investigations into the emergence of pertactin-deficient <italic>Bordetella pertussis</italic> isolates in six European countries, 1996 to 2012</article-title><source>Euro Surveill</source><year>2014</year><volume>19</volume><fpage>20881</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.ES2014.19.33.20881</pub-id><pub-id pub-id-type="pmid">25166348</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaji</surname><given-names>Y</given-names></name><name><surname>Otsuka</surname><given-names>N</given-names></name><name><surname>Toyoizumi-Ajisaka</surname><given-names>H</given-names></name><name><surname>Shibayama</surname><given-names>K</given-names></name><name><surname>Kamachi</surname><given-names>K</given-names></name></person-group><article-title>Genetic analysis of <italic>Bordetella pertussis</italic> isolates from the 2008&#x02013;2010 pertussis epidemic in Japan</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><elocation-id>e77165</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0077165</pub-id><pub-id pub-id-type="pmid">24124606</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otsuka</surname><given-names>N</given-names></name><name><surname>Han</surname><given-names>H-J</given-names></name><name><surname>Toyoizumi-Ajisaka</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Arakawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Prevalence and genetic characterization of pertactin-deficient <italic>Bordetella pertussis</italic> in Japan</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><elocation-id>e31985</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0031985</pub-id><pub-id pub-id-type="pmid">22348138</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodilis</surname><given-names>H</given-names></name><name><surname>Guiso</surname><given-names>N</given-names></name></person-group><article-title>Virulence of pertactin-negative <italic>Bordetella pertussis</italic> isolates from infants, France</article-title><source>Emerg Infect Dis</source><year>2013</year><volume>19</volume><fpage>471</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.3201/eid1903.121475</pub-id><pub-id pub-id-type="pmid">23621904</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>M</given-names></name><name><surname>Mcintyre</surname><given-names>PB</given-names></name><name><surname>Blyth</surname><given-names>CC</given-names></name><name><surname>Wood</surname><given-names>N</given-names></name><name><surname>Octavia</surname><given-names>S</given-names></name><etal/></person-group><article-title>The relationship between <italic>Bordetella pertussis</italic> genotype and clinical severity in Australian children with pertussis</article-title><source>J Infect</source><year>2016</year><volume>72</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2015.11.004</pub-id><pub-id pub-id-type="pmid">26675318</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegerle</surname><given-names>N</given-names></name><name><surname>Dore</surname><given-names>G</given-names></name><name><surname>Guiso</surname><given-names>N</given-names></name></person-group><article-title>Pertactin deficient <italic>Bordetella pertussis</italic> present a better fitness in mice immunized with an acellular pertussis vaccine</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>6597</fpage><lpage>6600</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2014.09.068</pub-id><pub-id pub-id-type="pmid">25312274</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safarchi</surname><given-names>A</given-names></name><name><surname>Octavia</surname><given-names>S</given-names></name><name><surname>Luu</surname><given-names>LDW</given-names></name><name><surname>Tay</surname><given-names>CY</given-names></name><name><surname>Sintchenko</surname><given-names>V</given-names></name><etal/></person-group><article-title>Pertactin negative <italic>Bordetella pertussis</italic> demonstrates higher fitness under vaccine selection pressure in a mixed infection model</article-title><source>Vaccine</source><year>2015</year><volume>33</volume><fpage>6277</fpage><lpage>6281</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2015.09.064</pub-id><pub-id pub-id-type="pmid">26432908</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiramatsu</surname><given-names>Y</given-names></name><name><surname>Miyaji</surname><given-names>Y</given-names></name><name><surname>Otsuka</surname><given-names>N</given-names></name><name><surname>Arakawa</surname><given-names>Y</given-names></name><name><surname>Shibayama</surname><given-names>K</given-names></name><etal/></person-group><article-title>Significant decrease in pertactin-deficient <italic>Bordetella pertussis</italic> isolates, Japan</article-title><source>Emerg Infect Dis</source><year>2017</year><volume>23</volume><fpage>699</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.3201/eid2304.161575</pub-id><pub-id pub-id-type="pmid">28322702</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safarchi</surname><given-names>A</given-names></name><name><surname>Octavia</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>SZ</given-names></name><name><surname>Kaur</surname><given-names>S</given-names></name><name><surname>Sintchenko</surname><given-names>V</given-names></name><etal/></person-group><article-title>Genomic dissection of Australian <italic>Bordetella pertussis</italic> isolates from the 2008&#x02013;2012 epidemic</article-title><source>J Infect</source><year>2016</year><volume>72</volume><fpage>468</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2016.01.005</pub-id><pub-id pub-id-type="pmid">26826518</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Gr&#x000f6;ndahl-Yli-Hannuksila</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>L</given-names></name><etal/></person-group><article-title>Whole-genome sequencing reveals the effect of vaccination on the evolution of <italic>Bordetella pertussis</italic></article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>12888</fpage><pub-id pub-id-type="doi">10.1038/srep12888</pub-id><pub-id pub-id-type="pmid">26283022</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>KE</given-names></name><name><surname>Weigand</surname><given-names>MR</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Cassiday</surname><given-names>PK</given-names></name><name><surname>Sammons</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genome structural diversity among 31 <italic>Bordetella pertussis</italic> isolates from two recent U.S. whooping cough statewide epidemics</article-title><source>mSphere</source><year>2016</year><volume>1</volume><elocation-id>e00036-16</elocation-id><pub-id pub-id-type="doi">10.1128/mSphere.00036-16</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><year>2015</year><article-title>Snippy: fast bacterial variant calling from NGS reads</article-title><ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/snippy">https://github.com/tseemann/snippy</ext-link><comment>accessed 20 September, 2017</comment></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weigand</surname><given-names>MR</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Loparev</surname><given-names>V</given-names></name><name><surname>Batra</surname><given-names>D</given-names></name><name><surname>Bowden</surname><given-names>KE</given-names></name><etal/></person-group><article-title>The history of <italic>Bordetella pertussis</italic> genome evolution includes structural rearrangement</article-title><source>J Bacteriol</source><year>2017</year><volume>199</volume><elocation-id>e00806-16</elocation-id><lpage>16</lpage><pub-id pub-id-type="doi">10.1128/JB.00806-16</pub-id><pub-id pub-id-type="pmid">28167525</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bart</surname><given-names>MJ</given-names></name><name><surname>van der Heide</surname><given-names>HGJ</given-names></name><name><surname>Zeddeman</surname><given-names>A</given-names></name><name><surname>Heuvelman</surname><given-names>K</given-names></name><name><surname>van Gent</surname><given-names>M</given-names></name><etal/></person-group><article-title>Complete genome sequences of 11 <italic>Bordetella pertussis</italic> strains representing the pandemic ptxP3 lineage</article-title><source>Genome Announc</source><year>2015</year><volume>3</volume><elocation-id>e01394-15</elocation-id><pub-id pub-id-type="doi">10.1128/genomeA.01394-15</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bart</surname><given-names>MJ</given-names></name><name><surname>Zeddeman</surname><given-names>A</given-names></name><name><surname>van der Heide</surname><given-names>HGJ</given-names></name><name><surname>Heuvelman</surname><given-names>K</given-names></name><name><surname>van Gent</surname><given-names>M</given-names></name><etal/></person-group><article-title>Complete genome sequences of <italic>Bordetella pertussis</italic> isolates B1917 and B1920, representing two predominant global lineages</article-title><source>Genome Announc</source><year>2014</year><volume>2</volume><elocation-id>e01301-14</elocation-id><pub-id pub-id-type="doi">10.1128/genomeA.01301-14</pub-id><pub-id pub-id-type="pmid">25540342</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Buboltz</surname><given-names>AM</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Schuster</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Comparative genomics of the classical <italic>Bordetella</italic> subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens</article-title><source>BMC Genomics</source><year>2012</year><volume>13</volume><elocation-id>545</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-13-545</pub-id><pub-id pub-id-type="pmid">23051057</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Harvill</surname><given-names>ET</given-names></name><name><surname>Dudley</surname><given-names>EG</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Diversity of secretion systems associated with virulence characteristics of the classical bordetellae</article-title><source>Microbiology</source><year>2015</year><volume>161</volume><fpage>2328</fpage><lpage>2340</lpage><pub-id pub-id-type="doi">10.1099/mic.0.000197</pub-id><pub-id pub-id-type="pmid">26459829</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gates</surname><given-names>I</given-names></name><name><surname>DuVall</surname><given-names>M</given-names></name><name><surname>Ju</surname><given-names>H</given-names></name><name><surname>Tondella</surname><given-names>ML</given-names></name><name><surname>Pawloski</surname><given-names>L</given-names></name><etal/></person-group><article-title>Development of a qualitative assay for screening of <italic>Bordetella pertussis</italic> isolates for pertussis toxin production</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><elocation-id>e0175326</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0175326</pub-id><pub-id pub-id-type="pmid">28394915</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>MN</given-names></name><name><surname>Dehal</surname><given-names>PS</given-names></name><name><surname>Arkin</surname><given-names>AP</given-names></name></person-group><article-title>FastTree 2 &#x02013; approximately maximum-likelihood trees for large alignments</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><elocation-id>e9490</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0009490</pub-id><pub-id pub-id-type="pmid">20224823</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Sebaihia</surname><given-names>M</given-names></name><name><surname>Preston</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>LD</given-names></name><name><surname>Thomson</surname><given-names>N</given-names></name><etal/></person-group><article-title>Comparative analysis of the genome sequences of <italic>Bordetella pertussis</italic>, <italic>Bordetella parapertussis</italic> and <italic>Bordetella bronchiseptica</italic></article-title><source>Nat Genet</source><year>2003</year><volume>35</volume><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1038/ng1227</pub-id><pub-id pub-id-type="pmid">12910271</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letunic</surname><given-names>I</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name></person-group><article-title>Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees</article-title><source>Nucleic Acids Res</source><year>2016</year><volume>44</volume><fpage>W242</fpage><lpage>W245</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw290</pub-id><pub-id pub-id-type="pmid">27095192</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>W-F</given-names></name><name><surname>Maharjan</surname><given-names>RP</given-names></name><name><surname>Reeves</surname><given-names>PR</given-names></name><name><surname>Sintchenko</surname><given-names>V</given-names></name><name><surname>Gilbert</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Rapid and accurate typing of <italic>Bordetella pertussis</italic> targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis</article-title><source>J Microbiol Methods</source><year>2009</year><volume>77</volume><fpage>326</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.mimet.2009.03.007</pub-id><pub-id pub-id-type="pmid">19341769</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muyldermans</surname><given-names>G</given-names></name><name><surname>Pierard</surname><given-names>D</given-names></name><name><surname>Hoebrekx</surname><given-names>N</given-names></name><name><surname>Advani</surname><given-names>R</given-names></name><name><surname>van Amersfoorth</surname><given-names>S</given-names></name><etal/></person-group><article-title>Simple algorithm for identification of <italic>Bordetella pertussis</italic> pertactin gene variants</article-title><source>J Clin Microbiol</source><year>2004</year><volume>42</volume><fpage>1614</fpage><lpage>1619</lpage><pub-id pub-id-type="doi">10.1128/JCM.42.4.1614-1619.2004</pub-id><pub-id pub-id-type="pmid">15071014</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treangen</surname><given-names>TJ</given-names></name><name><surname>Ondov</surname><given-names>BD</given-names></name><name><surname>Koren</surname><given-names>S</given-names></name><name><surname>Phillippy</surname><given-names>AM</given-names></name></person-group><article-title>The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><fpage>524</fpage><pub-id pub-id-type="doi">10.1186/s13059-014-0524-x</pub-id><pub-id pub-id-type="pmid">25410596</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>AJ</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name></person-group><article-title>BEAST: Bayesian evolutionary analysis by sampling trees</article-title><source>BMC Evol Biol</source><year>2007</year><volume>7</volume><fpage>214</fpage><pub-id pub-id-type="doi">10.1186/1471-2148-7-214</pub-id><pub-id pub-id-type="pmid">17996036</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>AJ</given-names></name><name><surname>Cummins</surname><given-names>CA</given-names></name><name><surname>Hunt</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>VK</given-names></name><name><surname>Reuter</surname><given-names>S</given-names></name><etal/></person-group><article-title>Roary: rapid large-scale prokaryote pan genome analysis</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>3691</fpage><lpage>3693</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv421</pub-id><pub-id pub-id-type="pmid">26198102</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tizolova</surname><given-names>A</given-names></name><name><surname>Guiso</surname><given-names>N</given-names></name><name><surname>Guillot</surname><given-names>S</given-names></name></person-group><article-title>Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2013</year><volume>32</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1007/s10096-012-1718-3</pub-id><pub-id pub-id-type="pmid">22886091</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fry</surname><given-names>NK</given-names></name><name><surname>Neal</surname><given-names>S</given-names></name><name><surname>Harrison</surname><given-names>TG</given-names></name><name><surname>Miller</surname><given-names>E</given-names></name><name><surname>Matthews</surname><given-names>R</given-names></name><etal/></person-group><article-title>Genotypic variation in the <italic>Bordetella pertussis</italic> virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom</article-title><source>Infect Immun</source><year>2001</year><volume>69</volume><fpage>5520</fpage><lpage>5528</lpage><pub-id pub-id-type="doi">10.1128/IAI.69.9.5520-5528.2001</pub-id><pub-id pub-id-type="pmid">11500425</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>du</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Luan</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Direct molecular typing of <italic>Bordetella pertussis</italic> from nasopharyngeal specimens in China in 2012&#x02013;2013</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2016</year><volume>35</volume><fpage>1211</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1007/s10096-016-2655-3</pub-id><pub-id pub-id-type="pmid">27146879</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galit</surname><given-names>SR</given-names></name><name><surname>Otsuka</surname><given-names>N</given-names></name><name><surname>Furuse</surname><given-names>Y</given-names></name><name><surname>Almonia</surname><given-names>DJ</given-names></name><name><surname>Sombrero</surname><given-names>LT</given-names></name><etal/></person-group><article-title>Molecular epidemiology of <italic>Bordetella pertussis</italic> in the Philippines in 2012&#x02013;2014</article-title><source>Int J Infect Dis</source><year>2015</year><volume>35</volume><fpage>24</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2015.04.001</pub-id><pub-id pub-id-type="pmid">25861926</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komatsu</surname><given-names>E</given-names></name><name><surname>Yamaguchi</surname><given-names>F</given-names></name><name><surname>Abe</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>AA</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name></person-group><article-title>Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model</article-title><source>Clin Vaccine Immunol</source><year>2010</year><volume>17</volume><fpage>807</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1128/CVI.00449-09</pub-id><pub-id pub-id-type="pmid">20357056</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caro</surname><given-names>V</given-names></name><name><surname>Elomaa</surname><given-names>A</given-names></name><name><surname>Brun</surname><given-names>D</given-names></name><name><surname>Mertsola</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><etal/></person-group><article-title><italic>Bordetella pertussis</italic> , Finland and France</article-title><source>Emerg Infect Dis</source><year>2006</year><volume>12</volume><fpage>987</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.3201/eid1206.051283</pub-id><pub-id pub-id-type="pmid">16707058</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>C</given-names></name><name><surname>Boursaux-Eude</surname><given-names>C</given-names></name><name><surname>Coralie</surname><given-names>G</given-names></name><name><surname>Caro</surname><given-names>V</given-names></name><name><surname>Guiso</surname><given-names>N</given-names></name></person-group><article-title>Polymorphism of <italic>Bordetella pertussis</italic> isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years</article-title><source>J Clin Microbiol</source><year>2001</year><volume>39</volume><fpage>4396</fpage><lpage>4403</lpage><pub-id pub-id-type="doi">10.1128/JCM.39.12.4396-4403.2001</pub-id><pub-id pub-id-type="pmid">11724851</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poynten</surname><given-names>M</given-names></name><name><surname>Mcintyre</surname><given-names>PB</given-names></name><name><surname>Mooi</surname><given-names>FR</given-names></name><name><surname>Heuvelman</surname><given-names>KJ</given-names></name><name><surname>Gilbert</surname><given-names>GL</given-names></name></person-group><article-title>Temporal trends in circulating <italic>Bordetella pertussis</italic> strains in Australia</article-title><source>Epidemiol Infect</source><year>1999</year><volume>132</volume><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1017/S095026880300164X</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breakwell</surname><given-names>L</given-names></name><name><surname>Kelso</surname><given-names>P</given-names></name><name><surname>Finley</surname><given-names>C</given-names></name><name><surname>Schoenfeld</surname><given-names>S</given-names></name><name><surname>Goode</surname><given-names>B</given-names></name><etal/></person-group><article-title>Pertussis vaccine effectiveness in the setting of pertactin-deficient pertussis</article-title><source>Pediatrics</source><year>2016</year><volume>137</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi">10.1542/peds.2015-3973</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vodzak</surname><given-names>J</given-names></name><name><surname>Queenan</surname><given-names>AM</given-names></name><name><surname>Souder</surname><given-names>E</given-names></name><name><surname>Evangelista</surname><given-names>AT</given-names></name><name><surname>Long</surname><given-names>SS</given-names></name></person-group><article-title>Clinical manifestations and molecular characterization of pertactin-deficient and pertactin-producing <italic>Bordetella pertussis</italic> in children, Philadelphia 2007&#x02013;2014</article-title><source>Clin Infect Dis</source><year>2017</year><volume>64</volume><fpage>60</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1093/cid/ciw632</pub-id><pub-id pub-id-type="pmid">27624959</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuel</surname><given-names>M</given-names></name><name><surname>Lefebvre</surname><given-names>B</given-names></name><name><surname>Whyte</surname><given-names>K</given-names></name><name><surname>Hayden</surname><given-names>K</given-names></name><name><surname>de Serres</surname><given-names>G</given-names></name><etal/></person-group><article-title>Antigenic and genetic characterization of <italic>Bordetella pertussis</italic> recovered from Quebec, Canada, 2002&#x02013;2014: detection of a genetic shift</article-title><source>Can J Microbiol</source><year>2016</year><volume>62</volume><fpage>437</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1139/cjm-2015-0781</pub-id><pub-id pub-id-type="pmid">26910633</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weigand</surname><given-names>MR</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Cassiday</surname><given-names>PK</given-names></name><name><surname>Loparev</surname><given-names>VN</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><etal/></person-group><article-title>Complete genome sequences of <italic>Bordetella pertussis</italic> isolates with novel pertactin-deficient deletions</article-title><source>Genome Announc</source><year>2017</year><volume>5</volume><elocation-id>e00973-17</elocation-id><pub-id pub-id-type="doi">10.1128/genomeA.00973-17</pub-id><pub-id pub-id-type="pmid">28912323</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litt</surname><given-names>DJ</given-names></name><name><surname>Neal</surname><given-names>SE</given-names></name><name><surname>Fry</surname><given-names>NK</given-names></name></person-group><article-title>Changes in genetic diversity of the <italic>Bordetella pertussis</italic> population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type</article-title><source>J Clin Microbiol</source><year>2009</year><volume>47</volume><fpage>680</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1128/JCM.01838-08</pub-id><pub-id pub-id-type="pmid">19158267</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brickman</surname><given-names>TJ</given-names></name><name><surname>Anderson</surname><given-names>MT</given-names></name><name><surname>Armstrong</surname><given-names>SK</given-names></name></person-group><article-title>Bordetella iron transport and virulence</article-title><source>Biometals</source><year>2007</year><volume>20</volume><fpage>303</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1007/s10534-006-9031-1</pub-id><pub-id pub-id-type="pmid">17295050</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>MG</given-names></name><name><surname>Weiss</surname><given-names>AA</given-names></name></person-group><article-title>BrkA protein of <italic>Bordetella pertussis</italic> inhibits the classical pathway of complement after C1 deposition</article-title><source>Infect Immun</source><year>2001</year><volume>69</volume><fpage>3067</fpage><lpage>3072</lpage><pub-id pub-id-type="doi">10.1128/IAI.69.5.3067-3072.2001</pub-id><pub-id pub-id-type="pmid">11292725</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>MR</given-names></name><name><surname>Peabody</surname><given-names>CR</given-names></name><name><surname>Partovi</surname><given-names>SM</given-names></name><name><surname>Zhai</surname><given-names>Y</given-names></name><name><surname>Tseng</surname><given-names>YH</given-names></name><etal/></person-group><article-title>Protein-translocating outer membrane porins of Gram-negative bacteria</article-title><source>Biochim Biophys Acta</source><year>2002</year><volume>1562</volume><fpage>6</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/S0005-2736(02)00359-0</pub-id><pub-id pub-id-type="pmid">11988218</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>GR</given-names></name><name><surname>Bernier</surname><given-names>RH</given-names></name><name><surname>Esber</surname><given-names>EC</given-names></name><name><surname>Hardegree</surname><given-names>MC</given-names></name><name><surname>Hinman</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists</article-title><source>JAMA</source><year>1987</year><volume>257</volume><fpage>1351</fpage><lpage>1356</lpage><pub-id pub-id-type="pmid">3820444</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>T</given-names></name></person-group><article-title>Vaccine chronicle in Japan</article-title><source>J Infect Chemother</source><year>2013</year><volume>19</volume><fpage>787</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1007/s10156-013-0641-6</pub-id><pub-id pub-id-type="pmid">23835871</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Infectious Disease Surveillance Center, Japan</collab></person-group><year>1997</year><article-title>Infectious Agents Surveillance Report: Pertussis, Japan, 1982&#x02013;1996</article-title><ext-link ext-link-type="uri" xlink:href="http://idsc.nih.go.jp/iasr/18/207/tpc207.html">http://idsc.nih.go.jp/iasr/18/207/tpc207.html</ext-link><comment>accessed 02/27/2017</comment></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Loo</surname><given-names>IHM</given-names></name><name><surname>Mooi</surname><given-names>FR</given-names></name></person-group><article-title>Changes in the Dutch <italic>Bordetella pertussis</italic> population in the first 20 years after the introduction of whole-cell vaccines</article-title><source>Microbiology</source><year>2002</year><volume>148</volume><fpage>2011</fpage><lpage>2018</lpage><pub-id pub-id-type="doi">10.1099/00221287-148-7-2011</pub-id><pub-id pub-id-type="pmid">12101289</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Loo</surname><given-names>IHM</given-names></name><name><surname>van der Heide</surname><given-names>HGJ</given-names></name><name><surname>Nagelkerke</surname><given-names>NJD</given-names></name><name><surname>Verhoef</surname><given-names>J</given-names></name><name><surname>Mooi</surname><given-names>FR</given-names></name></person-group><article-title>Temporal trends in the population structure of <italic>Bordetella pertussis</italic> during 1949&#x02013;1996 in a highly vaccinated population</article-title><source>J Infect Dis</source><year>1999</year><volume>179</volume><fpage>915</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1086/314690</pub-id><pub-id pub-id-type="pmid">10068587</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Infectious Disease Surveillance Center, Japan</collab></person-group><year>2008</year><article-title>Infectious Agents Surveillance Report: Pertussis, Japan, 2005&#x02013;2007</article-title><ext-link ext-link-type="uri" xlink:href="http://idsc.nih.go.jp/iasr/29/337/tpc337.html">http://idsc.nih.go.jp/iasr/29/337/tpc337.html</ext-link><comment>accessed 02/27/2017</comment></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>National Institute of Infectious Diseases, Japan</collab></person-group><year>2015</year><article-title>NESID Annual Surveillance Data Sentinel-Reporting Diseaes 2014-2</article-title><ext-link ext-link-type="uri" xlink:href="www.nih.go.jp/niid/en/survei/2085-idwr/ydata/6054-report-eb2014-2.html">www.nih.go.jp/niid/en/survei/2085-idwr/ydata/6054-report-eb2014-2.html</ext-link><comment>accessed 02/27/2017</comment></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>National Institute of Infectious Diseases, Japan</collab></person-group><article-title>Pertussis, Japan, 2008-2011. Infectious Agents Surveillance Report 2012. p. 321-332</article-title><ext-link ext-link-type="uri" xlink:href="www.niid.go.jp/niid/en/iasren/865-iasr/3027-tpc394.html">www.niid.go.jp/niid/en/iasren/865-iasr/3027-tpc394.html</ext-link><comment>accessed 02/27/2017</comment></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Twillert</surname><given-names>I</given-names></name><name><surname>Bona&#x0010d;i&#x00107; Marinovi&#x00107;</surname><given-names>AA</given-names></name><name><surname>Kuipers</surname><given-names>B</given-names></name><name><surname>van Gaans-van den Brink</surname><given-names>JAM</given-names></name><name><surname>Sanders</surname><given-names>EAM</given-names></name><etal/></person-group><article-title>Impact of age and vaccination history on long-term serological responses after symptomatic <italic>B. pertussis</italic> infection, a high dimensional data analysis</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>40328</fpage><pub-id pub-id-type="doi">10.1038/srep40328</pub-id><pub-id pub-id-type="pmid">28091579</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorji</surname><given-names>D</given-names></name><name><surname>Mooi</surname><given-names>F</given-names></name><name><surname>Yantorno</surname><given-names>O</given-names></name><name><surname>Deora</surname><given-names>R</given-names></name><name><surname>Graham</surname><given-names>RM</given-names></name><etal/></person-group><article-title><italic>Bordetella pertussis</italic> virulence factors in the continuing evolution of whooping cough vaccines for improved performance</article-title><source>Med Microbiol Immunol</source><year>2018</year><volume>207</volume><pub-id pub-id-type="doi">10.1007/s00430-017-0524-z</pub-id><pub-id pub-id-type="pmid">29164393</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geurtsen</surname><given-names>J</given-names></name><name><surname>Fae</surname><given-names>KC</given-names></name><name><surname>van den Dobbelsteen</surname><given-names>GPJM</given-names></name></person-group><article-title>Importance of (antibody-dependent) complement-mediated serum killing in protection against <italic>Bordetella pertussis</italic></article-title><source>Expert Rev Vaccines</source><year>2014</year><volume>13</volume><fpage>1229</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1586/14760584.2014.944901</pub-id><pub-id pub-id-type="pmid">25081731</pub-id></element-citation></ref></ref-list></back></article>